BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020;41:1798-1800. [PMID: 32186331 DOI: 10.1093/eurheartj/ehaa231] [Cited by in Crossref: 292] [Cited by in F6Publishing: 254] [Article Influence: 292.0] [Reference Citation Analysis]
Number Citing Articles
1 Baral R, Ali O, Brett I, Reinhold J, Vassiliou VS. COVID-19: a pan-organ pandemic. Oxf Med Case Reports. 2020;2020:omaa107. [PMID: 33304597 DOI: 10.1093/omcr/omaa107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Monye I, Adelowo AB. Strengthening immunity through healthy lifestyle practices: Recommendations for lifestyle interventions in the management of COVID‐19. Lifestyle Medicine 2020;1. [DOI: 10.1002/lim2.7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Shafi AMA, Shaikh SA, Shirke MM, Iddawela S, Harky A. Cardiac manifestations in COVID-19 patients-A systematic review. J Card Surg. 2020;35:1988-2008. [PMID: 32652713 DOI: 10.1111/jocs.14808] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 20.5] [Reference Citation Analysis]
4 Suri JS, Puvvula A, Biswas M, Majhail M, Saba L, Faa G, Singh IM, Oberleitner R, Turk M, Chadha PS, Johri AM, Sanches JM, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Ahluwalia P, Kolluri R, Teji J, Maini MA, Agbakoba A, Dhanjil SK, Sockalingam M, Saxena A, Nicolaides A, Sharma A, Rathore V, Ajuluchukwu JNA, Fatemi M, Alizad A, Viswanathan V, Krishnan PR, Naidu S. COVID-19 pathways for brain and heart injury in comorbidity patients: A role of medical imaging and artificial intelligence-based COVID severity classification: A review. Comput Biol Med 2020;124:103960. [PMID: 32919186 DOI: 10.1016/j.compbiomed.2020.103960] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
5 Trinity JD, Craig JC, Fermoyle CC, McKenzie AI, Lewis MT, Park SH, Rondina MT, Richardson RS. Impact of presymptomatic COVID-19 on vascular and skeletal muscle function: a case study. J Appl Physiol (1985) 2021;130:1961-70. [PMID: 34002634 DOI: 10.1152/japplphysiol.00236.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chatzis DG, Magounaki KT, Pantazopoulos IN, Johnson EO, Tsioufis KP. COVID-19 pandemic and cardiovascular disease: where do we stand? Minerva Cardioangiol 2020;68:347-58. [PMID: 32472990 DOI: 10.23736/S0026-4725.20.05298-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
7 de Carranza M, Salazar DE, Troya J, Alcázar R, Peña C, Aragón E, Domínguez M, Torres J, Muñoz-Rivas N. Aortic thrombus in patients with severe COVID-19: review of three cases. J Thromb Thrombolysis 2021;51:237-42. [PMID: 32648092 DOI: 10.1007/s11239-020-02219-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Baptiste DL, Commodore-Mensah Y, Alexander KA, Jacques K, Wilson PR, Akomah J, Sharps P, Cooper LA. COVID-19: Shedding light on racial and health inequities in the USA. J Clin Nurs 2020;29:2734-6. [PMID: 32472591 DOI: 10.1111/jocn.15351] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
9 Liang C, Zhang W, Li S, Qin G. Coronary heart disease and COVID-19: A meta-analysis. Med Clin (Engl Ed) 2021;156:547-54. [PMID: 34109276 DOI: 10.1016/j.medcle.2020.12.021] [Reference Citation Analysis]
10 Sato K, Sinclair JE, Sadeghirad H, Fraser JF, Short KR, Kulasinghe A. Cardiovascular disease in SARS-CoV-2 infection. Clin Transl Immunology 2021;10:e1343. [PMID: 34512975 DOI: 10.1002/cti2.1343] [Reference Citation Analysis]
11 Poulakou G, Dimakakos E, Kollias A, Kyriakoulis KG, Rapti V, Trontzas I, Thanos C, Abdelrasoul M, Vantana T, Leontis K, Kakalou E, Argyraki K, Baraboutis I, Michelakis E, Giamarellos-Bourboulis E, Dimakou K, Tsoukalas G, Rapti A, Michelakis ED, Syrigos KN. Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study. In Vivo 2021;35:653-61. [PMID: 33402523 DOI: 10.21873/invivo.12305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
12 Del Turco S, Vianello A, Ragusa R, Caselli C, Basta G. COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge? Thromb Res 2020;196:143-51. [PMID: 32871306 DOI: 10.1016/j.thromres.2020.08.039] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
13 Dakhil ZA, Farhan HA. Cardiovascular Impacts of COVID-19 Pandemic: From Presentation to Management: Current and Future Perspectives. J Clin Exp Invest 2020;11:em00739. [DOI: 10.5799/jcei/7941] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Abdel-qadir H, Austin PC, Pang A, Fang J, Udell JA, Geerts WH, Mcnaughton CD, Jackevicius CA, Kwong JC, Yeh CH, Cox JL, Lee DS, Ko DT, Atzema CL. The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: A population-based cohort study. Thrombosis Research 2022;211:114-22. [DOI: 10.1016/j.thromres.2021.12.010] [Reference Citation Analysis]
15 Campione E, Cosio T, Rosa L, Lanna C, Di Girolamo S, Gaziano R, Valenti P, Bianchi L. Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation. Int J Mol Sci 2020;21:E4903. [PMID: 32664543 DOI: 10.3390/ijms21144903] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
16 Malekrah A, Fatahian A. A case report of a rare cardiac complication in novel coronavirus disease. Eur Heart J Case Rep 2020;4:1-4. [PMID: 33442589 DOI: 10.1093/ehjcr/ytaa323] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wang N, Zhang M, Su H, Huang Z, Lin Y, Zhang M. Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic. J Int Med Res 2020;48:300060520966151. [PMID: 33108941 DOI: 10.1177/0300060520966151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Ali Waggiallah H. Thrombosis Formation after COVID-19 Vaccination Immunological Aspects: Review Article. Saudi J Biol Sci 2021. [PMID: 34629931 DOI: 10.1016/j.sjbs.2021.09.065] [Reference Citation Analysis]
19 Podzolkov VI, Tarzimanova AI, Bragina AE, Shvedov II, Bykova EE, Ivannikov AA, Vasilyeva LV. Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 1: Predictors of the Development of an Unfavorable Prognosis. Racionalʹnaâ farmakoterapiâ v kardiologii 2022;17:825-30. [DOI: 10.20996/1819-6446-2021-11-03] [Reference Citation Analysis]
20 Kelesoglu S, Yilmaz Y, Ozkan E, Calapkorur B, Dursun ZB, Ulu-Kilic A, Elcık D. Usefulness of C-reactive protein/albumin ratio as a predictor of new-onset atrial fibrillation in SARS-COV-2. Biomark Med 2021;15:1167-75. [PMID: 34406031 DOI: 10.2217/bmm-2020-0866] [Reference Citation Analysis]
21 Augustine R, S A, Nayeem A, Salam SA, Augustine P, Dan P, Maureira P, Mraiche F, Gentile C, Hansbro PM, McClements L, Hasan A. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation. Chem Biol Interact 2021;351:109738. [PMID: 34740598 DOI: 10.1016/j.cbi.2021.109738] [Reference Citation Analysis]
22 Pagan Lassalle P, Meyer ML, Conners R, Zieff G, Rojas J, Faghy MA, Arena R, Vermeesch A, Joseph RP, Stoner L. Targeting Sedentary Behavior in Minority Populations as a Feasible Health Strategy During and Beyond COVID-19: On Behalf of ACSM-EIM and HL-PIVOT. Transl J Am Coll Sports Med 2021;6:e000174. [PMID: 34746382 DOI: 10.1249/tjx.0000000000000174] [Reference Citation Analysis]
23 Maitz T, Parfianowicz D, Vojtek A, Rajeswaran Y, Vyas AV, Gupta R. COVID-19 Cardiovascular Connection: A Review of Cardiac Manifestations in COVID-19 Infection and Treatment Modalities. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101186] [Reference Citation Analysis]
24 Liu J, Deswal A, Khalid U. COVID-19 myocarditis and long-term heart failure sequelae. Curr Opin Cardiol 2021;36:234-40. [PMID: 33394709 DOI: 10.1097/HCO.0000000000000832] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Raffaello WM, Huang I, Budi Siswanto B, Pranata R. In-depth review of cardiopulmonary support in COVID-19 patients with heart failure. WJC 2021;13:299-309. [DOI: 10.4330/wjc.v13.i8.299] [Reference Citation Analysis]
26 Masic I, Naser N, Zildzic M. Public Health Aspects of COVID-19 Infection with Focus on Cardiovascular Diseases. Mater Sociomed 2020;32:71-6. [PMID: 32410896 DOI: 10.5455/msm.2020.32.71-76] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
27 Costa JA, Silveira JA, Santos SCMD, Nogueira PP. Cardiovascular Implications in Patients Infected with Covid-19 and the Importance of Social Isolation to Reduce Dissemination of the Disease. Arq Bras Cardiol 2020;114:834-8. [PMID: 32491075 DOI: 10.36660/abc.20200243] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
28 Yun SH, Park BG, Jung EY, Kwon JY, Park YK, Kim HJ. Factors Affecting the Practice of Corona Virus Disease-19 Prevention Activities in Patients With Heart Diseases in Korea. Clin Nurs Res 2022;:10547738211068140. [PMID: 35164575 DOI: 10.1177/10547738211068140] [Reference Citation Analysis]
29 Guarracino F, Shernan SK, Tahan ME, Bertini P, Stone ME, Kachulis B, Paternoster G, Mukherjee C, Wouters P, Rex S. EACTA/SCA Recommendations for the Cardiac Anesthesia Management of Patients With Suspected or Confirmed COVID-19 Infection: An Expert Consensus From the European Association of Cardiothoracic Anesthesiology and Society of Cardiovascular Anesthesiologists With Endorsement From the Chinese Society of Cardiothoracic and Vascular Anesthesiology. J Cardiothorac Vasc Anesth 2021;35:1953-63. [PMID: 33766471 DOI: 10.1053/j.jvca.2021.02.039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Centurión OA, Miño LM, Scavenius KE. Severe Acute Respiratory Syndrome Coronavirus 2: The Importance of Prompt Detection of Cardiovascular Involvement. TOCMJ 2020;14:38-41. [DOI: 10.2174/18741924020140100038] [Reference Citation Analysis]
31 Dou Q, Wei X, Zhou K, Yang S, Jia P. Cardiovascular Manifestations and Mechanisms in Patients with COVID-19. Trends Endocrinol Metab 2020;31:893-904. [PMID: 33172748 DOI: 10.1016/j.tem.2020.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
32 Alwaqfi NR, Ibrahim KS. COVID-19: an update and cardiac involvement. J Cardiothorac Surg 2020;15:239. [PMID: 32907637 DOI: 10.1186/s13019-020-01299-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
33 Gómez-Mesa JE, Galindo-Coral S, Montes MC, Alarco W, Barisani JL, Magaña A, Perna ER, Romero A, Speranza M, Mendoza I, Wyss F. Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry. Glob Heart 2021;16:14. [PMID: 33833938 DOI: 10.5334/gh.925] [Reference Citation Analysis]
34 Jones ID. The impact of Covid-19 on cardiovascular health. Nurs Crit Care 2022;27:141-4. [PMID: 35384184 DOI: 10.1111/nicc.12756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Blagojevic NR, Bosnjakovic D, Vukomanovic V, Arsenovic S, Lazic JS, Tadic M. Acute pericarditis and severe acute respiratory syndrome coronavirus 2: Case report. Int J Infect Dis 2020;101:180-2. [PMID: 33002620 DOI: 10.1016/j.ijid.2020.09.1440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
36 Siddamreddy S, Thotakura R, Dandu V, Kanuru S, Meegada S. Corona Virus Disease 2019 (COVID-19) Presenting as Acute ST Elevation Myocardial Infarction. Cureus 2020;12:e7782. [PMID: 32337148 DOI: 10.7759/cureus.7782] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
37 Li FK, An DW, Guo QH, Zhang YQ, Qian JY, Hu WG, Li Y, Wang JG. Day-by-day blood pressure variability in hospitalized patients with COVID-19. J Clin Hypertens (Greenwich) 2021. [PMID: 34331839 DOI: 10.1111/jch.14338] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Garg N, McClafferty B, Ramgobin D, Golamari R, Jain R, Jain R. Cardiology and COVID-19: do we have sufficient information? Future Cardiol 2021;17:705-11. [PMID: 33124920 DOI: 10.2217/fca-2020-0126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Luchian ML, Lochy S, Motoc A, Belsack D, Magne J, Roosens B, de Mey J, Tanaka K, Scheirlynck E, Boeckstaens S, Van den Bussche K, De Potter T, von Kemp B, Galloo X, François C, Weytjens C, Droogmans S, Cosyns B. Prognostic Value of Coronary Artery Calcium Score in Hospitalized COVID-19 Patients. Front Cardiovasc Med 2021;8:684528. [PMID: 34307498 DOI: 10.3389/fcvm.2021.684528] [Reference Citation Analysis]
40 Feldman C, Anderson R. Brief review: Cardiac complications and platelet activation in COVID-19 infection. Afr J Thorac Crit Care Med 2020;26. [PMID: 34235425 DOI: 10.7196/AJTCCM.2020.v26i3.107] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Tschöpe C, Sherif M, Anker MS, Geisel D, Kuehne T, Kelle S. COVID-19-convalescence phase unmasks a silent myocardial infarction due to coronary plaque rupture. ESC Heart Fail 2021;8:971-3. [PMID: 33410259 DOI: 10.1002/ehf2.13186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Tudoran C, Tudoran M, Lazureanu VE, Marinescu AR, Pop GN, Pescariu AS, Enache A, Cut TG. Evidence of Pulmonary Hypertension after SARS-CoV-2 Infection in Subjects without Previous Significant Cardiovascular Pathology. J Clin Med 2021;10:E199. [PMID: 33430492 DOI: 10.3390/jcm10020199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
43 Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr 2020;14:247-50. [PMID: 32247212 DOI: 10.1016/j.dsx.2020.03.013] [Cited by in Crossref: 305] [Cited by in F6Publishing: 249] [Article Influence: 152.5] [Reference Citation Analysis]
44 Abdel Moniem A, Radwan MA, Yousef AI. COVID-19 and cardiovascular disease: Manifestations, pathophysiology, vaccination, and long-term implication. Current Medical Research and Opinion. [DOI: 10.1080/03007995.2022.2078081] [Reference Citation Analysis]
45 Norris T, Razieh C, Zaccardi F, Yates T, Islam N, Gillies CL, Chudasama YV, Rowlands AV, Davies MJ, McCann GP, Banerjee A, Lam CSP, Docherty AB, Openshaw PJ, Baillie JK, Semple MG, Lawson CA, Khunti K; ISARIC4C investigators. Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19. Heart 2021:heartjnl-2021-320047. [PMID: 34911741 DOI: 10.1136/heartjnl-2021-320047] [Reference Citation Analysis]
46 van den Heuvel FMA, Vos JL, Koop Y, van Dijk APJ, Duijnhouwer AL, de Mast Q, van de Veerdonk FL, Bosch F, Kok B, Netea MG, Hoogerwerf J, Hoefsloot W, Tjwa ETTL, de Korte CL, van Kimmenade RRJ, Nijveldt R. Cardiac function in relation to myocardial injury in hospitalised patients with COVID-19. Neth Heart J 2020;28:410-7. [PMID: 32643071 DOI: 10.1007/s12471-020-01458-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
47 Negreira-Caamaño M, Río JM, Águila-Gordo D, Mateo-Gómez C, Soto-Pérez M, Piqueras-Flores J. [Cardiovascular events after COVID-19 hospitalization: long-term follow-up]. Rev Esp Cardiol 2021. [PMID: 34334882 DOI: 10.1016/j.recesp.2021.07.009] [Reference Citation Analysis]
48 Jashari R, Van Esbroeck M, Vanhaebost J, Micalessi I, Kerschen A, Mastrobuoni S. The risk of transmission of the novel coronavirus (SARS-CoV-2) with human heart valve transplantation: evaluation of cardio-vascular tissues from two consecutive heart donors with asymptomatic COVID-19. Cell Tissue Bank 2021. [PMID: 33687611 DOI: 10.1007/s10561-021-09913-z] [Reference Citation Analysis]
49 Çakmak Karaaslan Ö, Özilhan MO, Maden O, Tüfekçioğlu O. Prevalence of cardiac involvement in home-based recovered coronavirus disease 2019 (COVID-19) patients: a retrospective observational study. Ir J Med Sci 2021. [PMID: 34714493 DOI: 10.1007/s11845-021-02824-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Liu J, Virani SS, Alam M, Denktas AE, Hamzeh I, Khalid U. Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker? Rev Med Virol 2021;31:e2172. [PMID: 32959951 DOI: 10.1002/rmv.2172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Richter D, Guasti L, Koehler F, Squizzato A, Nistri S, Christodorescu R, Dievart F, Gaudio G, Asteggiano R, Ferrini M. Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice. ESC Heart Fail 2021. [PMID: 34170086 DOI: 10.1002/ehf2.13466] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Beura SK, Panigrahi AR, Yadav P, Singh SK. Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective. Front Pharmacol 2021;12:658273. [PMID: 33981235 DOI: 10.3389/fphar.2021.658273] [Reference Citation Analysis]
53 Lind L, Araujo JA, Barchowsky A, Belcher S, Berridge BR, Chiamvimonvat N, Chiu WA, Cogliano VJ, Elmore S, Farraj AK, Gomes AV, McHale CM, Meyer-Tamaki KB, Posnack NG, Vargas HM, Yang X, Zeise L, Zhou C, Smith MT. Key Characteristics of Cardiovascular Toxicants. Environ Health Perspect 2021;129:95001. [PMID: 34558968 DOI: 10.1289/EHP9321] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Zhan X, Dowell S, Shen Y, Lee DL. Chloroquine to fight COVID-19: A consideration of mechanisms and adverse effects? Heliyon 2020;6:e04900. [PMID: 32935064 DOI: 10.1016/j.heliyon.2020.e04900] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
55 Matos JHF, Gomes EB, Formiga NPF, Nascimento MNR, Lima GS, Moreira TMM. Interventions related to cardiovascular complications in people hospitalized by covid-19: a scoping review. Rev Bras Enferm 2021;74:e20200568. [PMID: 33566953 DOI: 10.1590/0034-7167-2020-0568] [Reference Citation Analysis]
56 Luo S, Qiu XM, Zeng XJ, Zhang DY, Wan B, Li X, Tian RH, Wang JT, Wang MY, Zhu J, Zhang C, Yang R, Chen F, Liang Y, Fan B, Jiang HJ, Wang XM, Chen W, Xu K, Gao JB, Du C, Zhang LN, Yang Y, Jia SJ, Ren H, Zu ZY, Xu PP, Zhong J, Yang YT, Zhou CS, Zhang W, Liu XX, Zhang QR, Xia F, Qi L, Lu MJ, Zhang LJ, Liu YX, Lu GM. Coronary artery calcification and risk of mortality and adverse outcomes in patients with COVID-19: a Chinese multicenter retrospective cohort study. Chin J Acad Radiol 2021;:1-9. [PMID: 34222797 DOI: 10.1007/s42058-021-00072-4] [Reference Citation Analysis]
57 Alareedh M, Nafakhi H, Shaghee F, Nafakhi A. Electrocardiographic markers of increased risk of sudden cardiac death in patients with COVID-19 pneumonia. Ann Noninvasive Electrocardiol 2021;26:e12824. [PMID: 33463863 DOI: 10.1111/anec.12824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
58 Marziliano N, Medoro A, Mignogna D, Saccon G, Folzani S, Reverberi C, Russo C, Intrieri M. Sudden Cardiac Death Caused by a Fatal Association of Hypertrophic Cardiomyopathy (MYH7, p.Arg719Trp), Heterozygous Familial Hypercholesterolemia (LDLR, p.Gly343Lys) and SARS-CoV-2 B.1.1.7 Infection. Diagnostics (Basel) 2021;11:1229. [PMID: 34359312 DOI: 10.3390/diagnostics11071229] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Abu-El-Rub E, Khasawneh RR, Almahasneh F, Altaany Z, Bataineh N, Zegallai H, Sekaran S. Mesenchymal stem cells and COVID-19: What they do and what they can do. World J Stem Cells 2021; 13(9): 1318-1337 [PMID: 34630865 DOI: 10.4252/wjsc.v13.i9.1318] [Reference Citation Analysis]
60 Albini A, Di Guardo G, Noonan DM, Lombardo M. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies. Intern Emerg Med 2020;15:759-66. [PMID: 32430651 DOI: 10.1007/s11739-020-02364-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 22.5] [Reference Citation Analysis]
61 Beri A, Kotak K. Cardiac injury, arrhythmia, and sudden death in a COVID-19 patient. HeartRhythm Case Rep 2020;6:367-9. [PMID: 32405457 DOI: 10.1016/j.hrcr.2020.05.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
62 Lüscher TF. COVID-19: (mis)managing an announced Black Swan. Eur Heart J 2020;41:1779-82. [PMID: 33216860 DOI: 10.1093/eurheartj/ehaa435] [Reference Citation Analysis]
63 D'Ascenzo F, De Filippo O, Borin A, Barbieri L, Adamo M, Morici N, Truffa Giachet A, Iannaccone M, Crimi G, Gaido L, Bocchino PP, Pivato CA, Campo G, Trabattoni D, Chieffo A, Gaibazzi N, Angelini F, Rubboli A, Rognoni A, Musumeci G, Ugo F, Gili S, Cortese B, Vadalà P, Dusi V, Gallone G, Patti G, de Ferrari GM. Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry. Int J Cardiol 2021;332:227-34. [PMID: 33794235 DOI: 10.1016/j.ijcard.2021.03.063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
64 Bevilacqua M, De Togni P, Cattazzo F, Dell'Atti D, Dalbeni A, Mazzaferri F, Tacconelli E, Farzaneh-Far A, Fava C, Minuz P, Romano S. Global Longitudinal Strain to Predict Respiratory Failure and Death in Patients Admitted for COVID-19-Related Disease. Am J Cardiol 2021:S0002-9149(21)01110-3. [PMID: 34895871 DOI: 10.1016/j.amjcard.2021.10.046] [Reference Citation Analysis]
65 Jin C, Kim MH, Lee KM, Park JS, Jung DS, Yun SC, Serebruany V. Less Myocardial Infarction and Stroke Hospitalizations During Middle East Respiratory Syndrome Coronavirus Epidemic in Korea. Am J Cardiol 2020;132:176-8. [PMID: 32747005 DOI: 10.1016/j.amjcard.2020.06.065] [Reference Citation Analysis]
66 Case BC, Yerasi C, Forrestal BJ, Shea C, Rappaport H, Medranda GA, Zhang C, Satler LF, Ben-Dor I, Hashim H, Rogers T, Waksman R. Comparison of Characteristics and Outcomes of Patients With Acute Myocardial Infarction With Versus Without Coronarvirus-19. Am J Cardiol 2021;144:8-12. [PMID: 33385357 DOI: 10.1016/j.amjcard.2020.12.059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
67 Bhandari B, Neupane S, Khanal R, Lnu K, Wert Y, Komanduri S. COVID-19 pericarditis mimicking an acute myocardial infarction: a case report and review of literature. J Community Hosp Intern Med Perspect 2021;11:315-21. [PMID: 34191989 DOI: 10.1080/20009666.2021.1896429] [Reference Citation Analysis]
68 Wibowo A, Pranata R, Astuti A, Tiksnadi BB, Martanto E, Martha JW, Purnomowati A, Akbar MR. Left and right ventricular longitudinal strains are associated with poor outcome in COVID-19: a systematic review and meta-analysis. J Intensive Care 2021;9:9. [PMID: 33436101 DOI: 10.1186/s40560-020-00519-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
69 Tudoran M, Tudoran C, Lazureanu VE, Marinescu AR, Pop GN, Pescariu AS, Enache A, Cut TG. Alterations of Left Ventricular Function Persisting during Post-Acute COVID-19 in Subjects without Previously Diagnosed Cardiovascular Pathology. J Pers Med 2021;11:225. [PMID: 33809873 DOI: 10.3390/jpm11030225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Garout MA, Saleh SAK, Adly HM, Abdulkhaliq AA, Khafagy AA, Abdeltawab MR, Rabaan AA, Rodriguez-Morales AJ, Al-Tawfiq JA, Alandiyjany MN. Post-COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia. Infection 2022. [PMID: 35294728 DOI: 10.1007/s15010-022-01788-w] [Reference Citation Analysis]
71 AlShoaibi NA, Maghrabi K, Alanazi H, Harbi MA, Alghamdi S. Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19. Ann Saudi Med 2020;40:365-72. [PMID: 32954790 DOI: 10.5144/0256-4947.2020.365] [Reference Citation Analysis]
72 Aragão RCA, Alves MC, Passos HD, Gonçalves LFG, Baumworcel L, Barreto Filho JAS. Myocardial Injury in COVID-19: a Challenge for Clinical Cardiologists. Arq Bras Cardiol 2020;115:139-41. [PMID: 32813832 DOI: 10.36660/abc.20200434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Chung MK, Zidar DA, Bristow MR, Cameron SJ, Chan T, Harding CV 3rd, Kwon DH, Singh T, Tilton JC, Tsai EJ, Tucker NR, Barnard J, Loscalzo J. COVID-19 and Cardiovascular Disease: From Bench to Bedside. Circ Res 2021;128:1214-36. [PMID: 33856918 DOI: 10.1161/CIRCRESAHA.121.317997] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
74 Stockenhuber A, Vrettos A, Androschuck V, George M, Robertson C, Bowers N, Clifford P, Firoozan S. A pilot study on right ventricular longitudinal strain as a predictor of outcome in COVID‐19 patients with evidence of cardiac involvement. Echocardiography 2021;38:222-9. [DOI: 10.1111/echo.14966] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
75 Al-Ghofaily L, Feinman JW, Augoustides JG. Fellowship Training in Adult Cardiothoracic Anesthesiology: Navigating the New Educational Landscape as a Result of the Coronavirus Crisis. J Cardiothorac Vasc Anesth 2020;34:2019-21. [PMID: 32387019 DOI: 10.1053/j.jvca.2020.04.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
76 Lessiani G, Boccatonda A, D'Ardes D, Cocco G, Di Marco G, Schiavone C. Mondor's Disease in SARS-CoV-2 Infection: A Case of Superficial Vein Thrombosis in the Era of COVID-19. Eur J Case Rep Intern Med 2020;7:001803. [PMID: 33083359 DOI: 10.12890/2020_001803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Zakeri A, Jadhav AP, Sullenger BA, Nimjee SM. Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist. J Neurointerv Surg 2021;13:202-6. [PMID: 33298508 DOI: 10.1136/neurintsurg-2020-016794] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
78 Gupta AK, Leslie A, Hewitt JN, Kovoor JG, Ovenden CD, Edwards S, Chan JCY, Worthington MG. Cardiac surgery on patients with COVID-19: a systematic review and meta-analysis. ANZ J Surg 2022. [PMID: 35373439 DOI: 10.1111/ans.17667] [Reference Citation Analysis]
79 Magnocavallo M, Vetta G, Della Rocca DG, Gianni C, Mohanty S, Bassiouny M, Di Lullo L, Del Prete A, Cirone D, Lavalle C, Chimenti C, Al-ahmad A, Burkhardt JD, Gallinghouse GJ, Sanchez JE, Horton RP, Di Biase L, Natale A. Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients. Cardiac Electrophysiology Clinics 2022. [DOI: 10.1016/j.ccep.2021.10.001] [Reference Citation Analysis]
80 Kim IC, Song JE, Lee HJ, Park JH, Hyun M, Lee JY, Kim HA, Kwon YS, Park JS, Youn JC, Hwang J, Lee CH, Cho YK, Park HS, Yoon HJ, Nam CW, Han S, Hur SH, Eisen HJ, Kim H. The Implication of Cardiac Injury Score on In-hospital Mortality of Coronavirus Disease 2019. J Korean Med Sci 2020;35:e349. [PMID: 33045772 DOI: 10.3346/jkms.2020.35.e349] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
81 AbdelMassih AF, Ramzy D, Nathan L, Aziz S, Ashraf M, Youssef NH, Hafez N, Saeed R, Agha H. Possible molecular and paracrine involvement underlying the pathogenesis of COVID-19 cardiovascular complications. Cardiovasc Endocrinol Metab 2020;9:121-4. [PMID: 32803146 DOI: 10.1097/XCE.0000000000000207] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
82 Loghin C, Chauhan S, Lawless SM. Pseudo-Acute Myocardial Infarction in a Young COVID-19 Patient. JACC Case Rep 2020;2:1284-8. [PMID: 32342049 DOI: 10.1016/j.jaccas.2020.04.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
83 Secco GG, Zocchi C, Parisi R, Roveta A, Mirabella F, Vercellino M, Pistis G, Reale M, Maggio S, Audo A, Kozel D, Centini G, Maconi A, Di Mario C. Decrease and Delay in Hospitalization for Acute Coronary Syndromes During the 2020 SARS-CoV-2 Pandemic. Can J Cardiol 2020;36:1152-5. [PMID: 32447060 DOI: 10.1016/j.cjca.2020.05.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
84 Dan S, Pant M, Upadhyay SK. The Case Fatality Rate in COVID-19 Patients With Cardiovascular Disease: Global Health Challenge and Paradigm in the Current Pandemic. Curr Pharmacol Rep 2020;:1-10. [PMID: 32953401 DOI: 10.1007/s40495-020-00239-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
85 Huang Z, Huang P, Du B, Kong L, Zhang W, Zhang Y, Dong J. Prevalence and clinical outcomes of cardiac injury in patients with COVID-19: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis 2021;31:2-13. [PMID: 33229199 DOI: 10.1016/j.numecd.2020.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
86 Kanthasamy V, Schilling RJ. Electrophysiology in the Era of Coronavirus Disease 2019. Arrhythm Electrophysiol Rev 2020;9:167-70. [PMID: 33240513 DOI: 10.15420/aer.2020.32] [Reference Citation Analysis]
87 Blumfield E, Levin TL. COVID-19 in pediatric patients: a case series from the Bronx, NY. Pediatr Radiol 2020;50:1369-74. [PMID: 32728901 DOI: 10.1007/s00247-020-04782-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
88 Marshall M. The lasting misery of coronavirus long-haulers. Nature 2020;585:339-41. [PMID: 32929257 DOI: 10.1038/d41586-020-02598-6] [Cited by in Crossref: 88] [Cited by in F6Publishing: 86] [Article Influence: 44.0] [Reference Citation Analysis]
89 Yenerçağ M, Arslan U, Doğduş M, Günal Ö, Öztürk ÇE, Aksan G, Erdoğan G, Gül S, Yontar OC, Şen A. Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19. J Electrocardiol 2020;62:5-9. [PMID: 32731139 DOI: 10.1016/j.jelectrocard.2020.07.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
90 da Costa CBP, Martins FJ, da Cunha LER, Ratcliffe NA, Cisne de Paula R, Castro HC. COVID-19 and Hyperimmune sera: A feasible plan B to fight against coronavirus. Int Immunopharmacol 2021;90:107220. [PMID: 33302034 DOI: 10.1016/j.intimp.2020.107220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
91 Chow J, Alhussaini A, Calvillo-Argüelles O, Billia F, Luk A. Cardiovascular Collapse in COVID-19 Infection: The Role of Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO). CJC Open 2020;2:273-7. [PMID: 32363334 DOI: 10.1016/j.cjco.2020.04.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
92 Negreira-Caamaño M, Piqueras-Flores J, Martínez-DelRio J, Nieto-Sandoval-Martin-DeLaSierra P, Aguila-Gordo D, Mateo-Gomez C, Salas-Bravo D, Rodriguez-Martinez M, Negreira-Caamaño M. Impact of Treatment with Renin-Angiotensin System Inhibitors on Clinical Outcomes in Hypertensive Patients Hospitalized with COVID-19. High Blood Press Cardiovasc Prev 2020;27:561-8. [PMID: 32949380 DOI: 10.1007/s40292-020-00409-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
93 Yang C, Liu F, Liu W, Cao G, Liu J, Huang S, Zhu M, Tu C, Wang J, Xiong B. Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia. Int J Cardiol. 2020;. [PMID: 32979425 DOI: 10.1016/j.ijcard.2020.09.048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
94 Tanwar V, Adelstein JM, Wold LE. Double trouble: combined cardiovascular effects of particulate matter exposure and coronavirus disease 2019. Cardiovasc Res 2021;117:85-95. [PMID: 33084879 DOI: 10.1093/cvr/cvaa293] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
95 Purdy A, Ido F, Sterner S, Tesoriero E, Matthews T, Singh A. Myocarditis in COVID-19 presenting with cardiogenic shock: a case series. Eur Heart J Case Rep 2021;5:ytab028. [PMID: 33733043 DOI: 10.1093/ehjcr/ytab028] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 [DOI: 10.1101/2020.04.12.20062869] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Gioia MA, Okunade A, Friedman A, Ahmed MF, Syed RA. A Case of Myopericarditis and Cardiac Tamponade as the Initial Presentation of COVID-19 Infection. Cureus 2021;13:e12967. [PMID: 33654630 DOI: 10.7759/cureus.12967] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Shaghee F, Nafakhi H, Alareedh M, Nafakhi A, Al-Buthabhak K. ECG markers of malignant arrhythmias and in-hospital outcome of COVID-19 pneumonia. J Arrhythm 2021. [PMID: 33821177 DOI: 10.1002/joa3.12506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Gitt AK, Bernhardt A, Zahn R, Zeymer U, Grau A, Beutel ME, Werdan K. The COVID-19 Registry in Rhineland-Palatinate in the context of international registry activities documenting COVID-19 outcomes. Herz 2020;45:316-8. [PMID: 32333027 DOI: 10.1007/s00059-020-04928-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Morell-Garcia D, Ramos-Chavarino D, Bauça JM, Argente Del Castillo P, Ballesteros-Vizoso MA, García de Guadiana-Romualdo L, Gómez-Cobo C, Pou JA, Amezaga-Menéndez R, Alonso-Fernández A, Llompart I, García-Raja A. Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients. Sci Rep 2021;11:11134. [PMID: 34045530 DOI: 10.1038/s41598-021-90610-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Changal K, Veria S, Mack S, Paternite D, Sheikh SA, Patel M, Mir T, Sheikh M, Ramanathan PK. Myocardial injury in hospitalized COVID-19 patients: a retrospective study, systematic review, and meta-analysis. BMC Cardiovasc Disord 2021;21:626. [PMID: 34972516 DOI: 10.1186/s12872-021-02450-3] [Reference Citation Analysis]
102 Dherange P, Lang J, Qian P, Oberfeld B, Sauer WH, Koplan B, Tedrow U. Arrhythmias and COVID-19: A Review. JACC Clin Electrophysiol 2020;6:1193-204. [PMID: 32972561 DOI: 10.1016/j.jacep.2020.08.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
103 Kaliyaperumal D, Bhargavi K, Ramaraju K, Nair KS, Ramalingam S, Alagesan M. Electrocardiographic Changes in COVID-19 Patients: A Hospital-based Descriptive Study. Indian Journal of Critical Care Medicine 2022;26:43-8. [DOI: 10.5005/jp-journals-10071-24045] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Tomasoni D, Italia L, Adamo M, Inciardi RM, Lombardi CM, Solomon SD, Metra M. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail. 2020;22:957-966. [PMID: 32412156 DOI: 10.1002/ejhf.1871] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 42.0] [Reference Citation Analysis]
105 Fagundes AA, Melo SLD, Armaganijan L, Kuniyoshi R, Moraes LGBD, Borges VAG, Scanavacca M, Martinelli M, Teixeira RA. Cardiac Arrhythmias and Covid-19. International Journal of Cardiovascular Sciences 2021. [DOI: 10.36660/ijcs.20200123] [Reference Citation Analysis]
106 Cappannoli L, Scacciavillani R, Iannaccone G, Anastasia G, DI Giusto F, Crea F. 2019 novel Coronavirus: current knowledge, cardiovascular implications and management. Minerva Cardiol Angiol 2021;69:377-88. [PMID: 32472991 DOI: 10.23736/S2724-5683.20.05311-6] [Reference Citation Analysis]
107 Loffi M, Piccolo R, Regazzoni V, Di Tano G, Moschini L, Robba D, Quinzani F, Esposito G, Franzone A, Danzi GB. Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection. Open Heart 2020;7:e001428. [PMID: 33229434 DOI: 10.1136/openhrt-2020-001428] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
108 Varghese PM, Tsolaki AG, Yasmin H, Shastri A, Ferluga J, Vatish M, Madan T, Kishore U. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies. Immunobiology 2020;225:152008. [PMID: 33130519 DOI: 10.1016/j.imbio.2020.152008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
109 Aralova NI; V. M. Glushkov Institute of Cybernetics of National Academy of Sciences of Ukraine, Kyiv. MATHEMATICAL MODEL FOR THE INVESTIGATION OF HYPOXIC STATES IN THE HEART MUSCLE AT VIRAL DAMAGE. Biotechnol acta 2021;14:38-52. [DOI: 10.15407/biotech14.04.038] [Reference Citation Analysis]
110 Parlakpinar H, Gunata M. SARS-COV-2 (COVID-19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments. Cell Biochem Funct 2021;39:10-28. [PMID: 32992409 DOI: 10.1002/cbf.3591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
111 Böhm M, Frey N, Giannitsis E, Sliwa K, Zeiher AM. Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation. Clin Res Cardiol 2020;109:1446-59. [PMID: 32462267 DOI: 10.1007/s00392-020-01656-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
112 Labarrere CA, Kassab GS. Pattern Recognition Proteins: First Line of Defense Against Coronaviruses. Front Immunol 2021;12:652252. [PMID: 34630377 DOI: 10.3389/fimmu.2021.652252] [Reference Citation Analysis]
113 Gee S, Gaughran F, MacCabe J, Shergill S, Whiskey E, Taylor D. Management of clozapine treatment during the COVID-19 pandemic. Ther Adv Psychopharmacol 2020;10:2045125320928167. [PMID: 32542111 DOI: 10.1177/2045125320928167] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
114 Hossain MA, Kim J. Possibility as role of ginseng and ginsenosides on inhibiting the heart disease of COVID-19: A systematic review. Journal of Ginseng Research 2022. [DOI: 10.1016/j.jgr.2022.01.003] [Reference Citation Analysis]
115 Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri FC. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action. Thromb Res 2020;196:313-7. [PMID: 32977129 DOI: 10.1016/j.thromres.2020.09.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
116 Qiang Z, Wang B, Garrett BC, Rainey RP, Superko HR. Coronavirus disease 2019: a comprehensive review and meta-analysis on cardiovascular biomarkers. Curr Opin Cardiol 2021;36:367-73. [PMID: 33709980 DOI: 10.1097/HCO.0000000000000851] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, Tleyjeh IM. Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19. Front Immunol 2021;12:686029. [PMID: 34276671 DOI: 10.3389/fimmu.2021.686029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
118 Amin S, Aktar S, Rahman MM, Hassan Chowdhury MM. NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity. Microbes Infect 2021;:104913. [PMID: 34838941 DOI: 10.1016/j.micinf.2021.104913] [Reference Citation Analysis]
119 Gupta S, Mitra A. Challenge of post-COVID era: management of cardiovascular complications in asymptomatic carriers of SARS-CoV-2. Heart Fail Rev 2021. [PMID: 33426593 DOI: 10.1007/s10741-021-10076-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Basso C, Leone O, Rizzo S, De Gaspari M, van der Wal AC, Aubry MC, Bois MC, Lin PT, Maleszewski JJ, Stone JR. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur Heart J. 2020;41:3827-3835. [PMID: 32968776 DOI: 10.1093/eurheartj/ehaa664] [Cited by in Crossref: 108] [Cited by in F6Publishing: 109] [Article Influence: 108.0] [Reference Citation Analysis]
121 Agarwal MA, Ziaeian B, Lavie CJ, Fonarow GC. Cardiovascular Disease in Hospitalized Patients With a Diagnosis of Coronavirus From the Pre-COVID-19 Era in United States: National Analysis From 2016-2017. Mayo Clin Proc 2020;95:2674-83. [PMID: 33276839 DOI: 10.1016/j.mayocp.2020.09.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
122 Zieff G, Bates LC, Kerr ZY, Moore JB, Hanson ED, Battaglini C, Stoner L. Targeting sedentary behavior as a feasible health strategy during COVID-19. Transl Behav Med 2021;11:826-31. [PMID: 33118596 DOI: 10.1093/tbm/ibaa101] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
123 Nascimento CRD, Leão SC, Barbosa RHA, Tenório PP. Cardiovascular damage due to COVID-19: what do we need to know? Rev Assoc Med Bras (1992) 2021;67Suppl 1:121-6. [PMID: 34406302 DOI: 10.1590/1806-9282.67.Suppl1.20200706] [Reference Citation Analysis]
124 D'Souza R, Malhamé I, Teshler L, Acharya G, Hunt BJ, McLintock C. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstet Gynecol Scand 2020;99:1110-20. [PMID: 32678949 DOI: 10.1111/aogs.13962] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
125 Nalugo M, Schulte LJ, Masood MF, Zayed MA. Microvascular Angiopathic Consequences of COVID-19. Front Cardiovasc Med 2021;8:636843. [PMID: 33604359 DOI: 10.3389/fcvm.2021.636843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
126 Kogan EA, Berezovsky YS, Protsenko DD, Bagdasaryan TR, Gretsov EM, Demura SA, Demyashkin GA, Kalinin DV, Kukleva AD, Kurilina EV, Nekrasova TP, Paramonova NB, Ponomarev AB, Radenska-lopovok SG, Semyonova LA, Tertychny AS. PATHOLOGICAL ANATOMY OF INFECTION CAUSED BY SARS-COV-2. Sud med (Online) 2020;6:8-30. [DOI: 10.19048/2411-8729-2020-6-2-8-30] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 6.5] [Reference Citation Analysis]
127 Neumaier F, Zlatopolskiy BD, Neumaier B. Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics. Pharmaceutics 2020;12:E1247. [PMID: 33371500 DOI: 10.3390/pharmaceutics12121247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
128 Turagam MK, Musikantow D, Goldman ME, Bassily-Marcus A, Chu E, Shivamurthy P, Lampert J, Kawamura I, Bokhari M, Whang W, Bier BA, Malick W, Hashemi H, Miller MA, Choudry S, Pumill C, Ruiz-Maya T, Hadley M, Giustino G, Koruth JS, Langan N, Sofi A, Dukkipati SR, Halperin JL, Fuster V, Kohli-Seth R, Reddy VY. Malignant Arrhythmias in Patients With COVID-19: Incidence, Mechanisms, and Outcomes. Circ Arrhythm Electrophysiol 2020;13:e008920. [PMID: 33026892 DOI: 10.1161/CIRCEP.120.008920] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
129 Deng MC. Multi-dimensional COVID-19 short- and long-term outcome prediction algorithm. Expert Rev Precis Med Drug Dev 2020;5:239-42. [PMID: 33283045 DOI: 10.1080/23808993.2020.1785286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
130 Mulcahey MK, Gianakos AL, Mercurio A, Rodeo S, Sutton KM. Sports Medicine Considerations During the COVID-19 Pandemic. Am J Sports Med 2021;49:512-21. [PMID: 33196320 DOI: 10.1177/0363546520975186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
131 Rivera-Morales MD, Pell R, Rubero J, Ganti L. Acute Myopericarditis in the Post COVID-19 Recovery Phase. Cureus 2020;12:e11247. [PMID: 33274129 DOI: 10.7759/cureus.11247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
132 Jutzeler CR, Bourguignon L, Weis CV, Tong B, Wong C, Rieck B, Pargger H, Tschudin-Sutter S, Egli A, Borgwardt K, Walter M. Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020;37:101825. [PMID: 32763496 DOI: 10.1016/j.tmaid.2020.101825] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 23.5] [Reference Citation Analysis]
133 Dolci G, Prevedello F, Lobascio I, Mugnai G, Dalla Valle C, Bilato C. Mid-ventricular Takotsubo syndrome 'lockdown'-related during coronavirus disease 2019 outbreak: a case report. J Cardiovasc Med (Hagerstown) 2021;22:414-6. [PMID: 32941322 DOI: 10.2459/JCM.0000000000001054] [Reference Citation Analysis]
134 Starostin D, Kuzovlev A. Role of Pulmonary Ultrasound in COVID-19 Pandemics. CRMR 2021;17:3-7. [DOI: 10.2174/1573398x17666210301122718] [Reference Citation Analysis]
135 Bandopadhyay A, Singh AK, Chaubey G. COVID-19: The Cause of the Manifested Cardiovascular Complications During the Pandemic. Front Cardiovasc Med 2021;8:744482. [PMID: 34778405 DOI: 10.3389/fcvm.2021.744482] [Reference Citation Analysis]
136 Briguglio M, Porta M, Zuffada F, Bona AR, Crespi T, Pino F, Perazzo P, Mazzocchi M, Giorgino R, De Angelis G, Ielasi A, De Blasio G, Turiel M. SARS-CoV-2 Aiming for the Heart: A Multicenter Italian Perspective About Cardiovascular Issues in COVID-19. Front Physiol 2020;11:571367. [PMID: 33240098 DOI: 10.3389/fphys.2020.571367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
137 Sobh E, Reihan MS, Hifnawy TMS, Abdelsalam KG, Awad SS, Mahmoud NMH, Sindi NA, Alhadrami HA. Cardiovascular system and coronavirus disease-2019 (COVID-19): mutual injuries and unexpected outcomes. Egypt Heart J 2021;73:77. [PMID: 34478001 DOI: 10.1186/s43044-021-00202-4] [Reference Citation Analysis]
138 Grinevich VB, Gubonina IV, Doshchitsin VL, Kotovskaya YV, Kravchuk YA, Ped VI, Sas EI, Syrov AV, Tarasov AV, Tarzimanova AI, Tkacheva ON, Trukhan DI. Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020. Cardiovasc Ther Prev 2020;19:2630. [DOI: 10.15829/1728-8800-2020-2630] [Cited by in Crossref: 26] [Cited by in F6Publishing: 3] [Article Influence: 13.0] [Reference Citation Analysis]
139 Kogan EA, Kukleva AD, Berezovskiy YS, Blagova OV, Zharkov NV, Ainetdinova DK, Demyashkin GA. [Clinical and morphological characteristics of SARS-CoV-2-related myocarditis proven by the presence of viral RNA and proteins in myocardial tissue]. Arkh Patol 2021;83:5-13. [PMID: 34278755 DOI: 10.17116/patol2021830415] [Reference Citation Analysis]
140 Sisti N, Valente S, Mandoli GE, Santoro C, Sciaccaluga C, Franchi F, Cameli P, Mondillo S, Cameli M. COVID-19 in patients with heart failure: the new and the old epidemic. Postgrad Med J 2021;97:175-9. [PMID: 32732260 DOI: 10.1136/postgradmedj-2020-138080] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
141 Chan C, Foster ST, Chan KG, Cacace MJ, Ladd SL, Sandum CT, Wright PT, Volmert B, Yang W, Aguirre A, Li W, Wright NT. Repositioned Drugs for COVID-19-the Impact on Multiple Organs. SN Compr Clin Med 2021;:1-18. [PMID: 33898925 DOI: 10.1007/s42399-021-00874-8] [Reference Citation Analysis]
142 Maestrini V, Birtolo LI, Francone M, Galardo G, Galea N, Severino P, Alessandri F, Colaiacomo MC, Cundari G, Chimenti C, Lavalle C, Ciardi M, Palange P, Deales A, d'Ettorre G, Mastroianni CM, Catalano C, Ruberto F, Pugliese F, d'Amati G, Fedele F, Mancone M; Policlinico Umberto I COVID-19 Group. Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up. Int J Cardiol 2021;339:235-42. [PMID: 34224766 DOI: 10.1016/j.ijcard.2021.06.056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
143 Nain Z, Rana HK, Liò P, Islam SMS, Summers MA, Moni MA. Pathogenetic profiling of COVID-19 and SARS-like viruses. Brief Bioinform 2021;22:1175-96. [PMID: 32778874 DOI: 10.1093/bib/bbaa173] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
144 Rathore SS, Rojas GA, Sondhi M, Pothuru S, Pydi R, Kancherla N, Singh R, Ahmed NK, Shah J, Tousif S, Baloch UT, Wen Q. Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series. Int J Clin Pract 2021;:e14470. [PMID: 34235815 DOI: 10.1111/ijcp.14470] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
145 Sultan S, Acharya Y. Antimalarial and cytotoxic drugs on COVID-19 and the cardiovascular burden: Literature review and lessons to be learned. Vascular 2021;29:220-7. [PMID: 32691699 DOI: 10.1177/1708538120941635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Thachil J. The versatile heparin in COVID-19. J Thromb Haemost. 2020;18:1020-1022. [PMID: 32239799 DOI: 10.1111/jth.14821] [Cited by in Crossref: 199] [Cited by in F6Publishing: 195] [Article Influence: 99.5] [Reference Citation Analysis]
147 Park BE, Lee JH, Park HK, Kim HN, Jang SY, Bae MH, Yang DH, Park HS, Cho Y, Lee BY, Nam CW, Lee JB, Kim U, Chae SC; Daegu COVID-19 Research Project. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City. J Korean Med Sci 2021;36:e15. [PMID: 33429474 DOI: 10.3346/jkms.2021.36.e15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
148 Cordero A, Santos García-gallego C, Bertomeu-gonzález V, Fácila L, Rodríguez-mañero M, Escribano D, Castellano JM, Zuazola P, Núñez J, Badimón JJ, González-juanatey JR. Mortality associated with cardiovascular disease in patients with COVID-19. REC: CardioClinics 2021;56:30-8. [DOI: 10.1016/j.rccl.2020.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
149 Dos Anjos F, Simões JLB, Assmann CE, Carvalho FB, Bagatini MD. Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2. J Immunol Res 2020;2020:8632048. [PMID: 33299899 DOI: 10.1155/2020/8632048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
150 Shin CH, Kim KH, Jeeva S, Kang SM. Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome. Cells 2021;10:1412. [PMID: 34204163 DOI: 10.3390/cells10061412] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
151 Case BC, Yerasi C, Forrestal BJ, Shea C, Rappaport H, Medranda GA, Zhang C, Abramowitz J, Satler LF, Ben-Dor I, Hashim H, Rogers T, Waksman R. Clinical impact and predictors of troponin elevation in patients with COVID-19. Cardiovasc Revasc Med 2021:S1553-8389(21)00136-6. [PMID: 34053871 DOI: 10.1016/j.carrev.2021.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 D'Andrea A, Radmilovic J, Carbone A, Forni A, Tagliamonte E, Riegler L, Liccardo B, Crescibene F, Sirignano C, Esposito G, Bossone E. Multimodality imaging in COVID-19 patients: A key role from diagnosis to prognosis. World J Radiol 2020; 12(11): 261-271 [PMID: 33362917 DOI: 10.4329/wjr.v12.i11.261] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
153 Kumar S, Haqqani H, Wynn G, Pathak RK, Lipton J, Mahajan R, Sanders P, Healey S, Wilsmore B, Mariani JA, Thomas SP, Weerasooriya R, McGavigan A, Gould PA, Weatherley P, Saad N, Cowan M, Turnbull S, Trivic I, Wong M, Tonchev I, Morton JB, Skinner JR, Pflaumer A, McGuire M, Kistler P, Kalman JM; Cardiac Society of Australia and New Zealand (CSANZ) Heart Rhythm Council COVID-19 Pandemic Working Group. Position Statement on the Management of Cardiac Electrophysiology and Cardiac Implantable Electronic Devices in Australia During the COVID-19 Pandemic: A Living Document. Heart Lung Circ 2020;29:e57-68. [PMID: 32451232 DOI: 10.1016/j.hlc.2020.04.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
154 Sharma S, Mishra A, Ashraf Z. COVID-19 Induced Coagulopathy (CIC): Thrombotic Manifestations of Viral Infection. TH Open 2022;6:e70-9. [PMID: 35280973 DOI: 10.1055/s-0042-1744185] [Reference Citation Analysis]
155 Miftode RS, Petriș AO, Onofrei Aursulesei V, Cianga C, Costache II, Mitu O, Miftode IL, Șerban IL. The Novel Perspectives Opened by ST2 in the Pandemic: A Review of Its Role in the Diagnosis and Prognosis of Patients with Heart Failure and COVID-19. Diagnostics (Basel) 2021;11:175. [PMID: 33530550 DOI: 10.3390/diagnostics11020175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
156 Apetrii M, Enache S, Siriopol D, Burlacu A, Kanbay A, Kanbay M, Scripcariu D, Covic A. A brand-new cardiorenal syndrome in the COVID-19  setting. Clin Kidney J 2020;13:291-6. [PMID: 32695320 DOI: 10.1093/ckj/sfaa082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
157 Chen J, Kelley WJ, Goldstein DR. Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19. J Immunol 2020;205:313-20. [PMID: 32493812 DOI: 10.4049/jimmunol.2000380] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
158 Hessami A, Shamshirian A, Heydari K, Pourali F, Alizadeh-Navaei R, Moosazadeh M, Abrotan S, Shojaie L, Sedighi S, Shamshirian D, Rezaei N. Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis. Am J Emerg Med 2021;46:382-91. [PMID: 33268238 DOI: 10.1016/j.ajem.2020.10.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 13.5] [Reference Citation Analysis]
159 Lever A, Safra L. Rethinking the Epidemiogenic Power of Modern Western Societies. Front Sociol 2021;6:638777. [PMID: 34150904 DOI: 10.3389/fsoc.2021.638777] [Reference Citation Analysis]
160 Dedè L, Regazzoni F, Vergara C, Zunino P, Guglielmo M, Scrofani R, Fusini L, Cogliati C, Pontone G, Quarteroni A. Modeling the cardiac response to hemodynamic changes associated with COVID-19: a computational study. Math Biosci Eng 2021;18:3364-83. [PMID: 34198390 DOI: 10.3934/mbe.2021168] [Reference Citation Analysis]
161 Swol J, Lorusso R. Additive treatment considerations in COVID-19-The clinician's perspective on extracorporeal adjunctive purification techniques. Artif Organs 2020;44:918-25. [PMID: 32516506 DOI: 10.1111/aor.13748] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
162 Hebbard C, Lee B, Katare R, Garikipati VNS. Diabetes, Heart Failure, and COVID-19: An Update. Front Physiol 2021;12:706185. [PMID: 34721055 DOI: 10.3389/fphys.2021.706185] [Reference Citation Analysis]
163 Sun W, Zhang Y, Wu C, Xie Y, Peng L, Nie X, Yu C, Zheng Y, Li Y, Wang J, Yang Y, Lv Q, Zhang L, Taub CC, Xie M. Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients. Echocardiography 2021;38:1272-81. [PMID: 34184314 DOI: 10.1111/echo.15133] [Reference Citation Analysis]
164 Castiello T, Georgiopoulos G, Finocchiaro G, Claudia M, Gianatti A, Delialis D, Aimo A, Prasad S. COVID-19 and myocarditis: a systematic review and overview of current challenges. Heart Fail Rev 2021. [PMID: 33761041 DOI: 10.1007/s10741-021-10087-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
165 Balachandar V, Mahalaxmi I, Subramaniam M, Kaavya J, Senthil Kumar N, Laldinmawii G, Narayanasamy A, Janardhana Kumar Reddy P, Sivaprakash P, Kanchana S, Vivekanandhan G, Cho SG. Follow-up studies in COVID-19 recovered patients - is it mandatory? Sci Total Environ 2020;729:139021. [PMID: 32360909 DOI: 10.1016/j.scitotenv.2020.139021] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 24.5] [Reference Citation Analysis]
166 Iwanski J, Kazmouz SG, Li S, Stansfield B, Salem TT, Perez-Miller S, Kazui T, Jena L, Uhrlaub JL, Lick S, Nikolich-Žugich J, Konhilas JP, Gregorio CC, Khanna M, Campos SK, Churko JM. Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells. Stem Cell Reports 2021;16:2459-72. [PMID: 34525378 DOI: 10.1016/j.stemcr.2021.08.018] [Reference Citation Analysis]
167 Padiyar S, Danda D. Revisiting cardiac safety of hydroxychloroquine in rheumatological diseases during COVID-19 era: Facts and myths. Eur J Rheumatol 2020. [PMID: 33044166 DOI: 10.5152/eurjrheum.2020.20174] [Reference Citation Analysis]
168 Asdaghpour E, Baghaei R, Jalilifar N, Radmehr H, Shirzad M, Mirzaaghayan MR, Yousefnia MA, Austin N, Alizadeh Ghavidel A, Hossein Ahmadi Z, Amirghofran AA, Amin A, Babazadeh K, Parvizi R, Hosseini S, Jadbabaei AN, Jahangirifard A, Hekmat M, Shabani M, Sadeghipour P, Abbasi Tashnizee M, Gholampour Dehaki M, Firouzi A, Mirmohammadsadeghi M, Nikpajouh A. Iranian Society of Cardiac Surgeons Position Statement for the Treatment of Patients in Need of Cardiac Surgery in the COVID-19 Pandemic Period (Version I). Multidiscip Cardio Annal 2020;11. [DOI: 10.5812/mca.104296] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
169 Vicenzi M, Ruscica M, Jamialahmadi T, Sahebkar A. Cardiovascular complications of COVID-19: toward better understanding, diagnosis, monitoring and management. Expert Rev Anti Infect Ther 2021;:1-2. [PMID: 34343449 DOI: 10.1080/14787210.2021.1964695] [Reference Citation Analysis]
170 Sharp O, Masud D. Breast reconstruction with immediate autologous free tissue transfer in a peri-operative COVID-19 positive patient: A case report illustrating feasibility of aftercare. J Plast Reconstr Aesthet Surg 2021;74:644-710. [PMID: 33214114 DOI: 10.1016/j.bjps.2020.10.088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
171 Augoustides JG. Cardiovascular Consequences and Considerations of Coronavirus Infection - Perspectives for the Cardiothoracic Anesthesiologist and Intensivist During the Coronavirus Crisis. J Cardiothorac Vasc Anesth 2020;34:1713-6. [PMID: 32349897 DOI: 10.1053/j.jvca.2020.04.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
172 Capotosto L, Nguyen BL, Ciardi MR, Mastroianni C, Vitarelli A. Heart, COVID-19, and echocardiography. Echocardiography 2020;37:1454-64. [PMID: 32885490 DOI: 10.1111/echo.14834] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
173 Case BC, Abramowitz J, Shea C, Rappaport H, Yerasi C, Forrestal BJ, Chezar-Azerrad C, Medranda GA, Zhang C, Satler LF, Ben-Dor I, Hashim H, Rogers T, Weintraub WS, Waksman R. Evolution of Management and Outcomes of Patients with Myocardial Injury During the COVID-19 Pandemic. Am J Cardiol 2021:S0002-9149(21)00677-9. [PMID: 34384590 DOI: 10.1016/j.amjcard.2021.07.022] [Reference Citation Analysis]
174 . Primer on the Pathogenesis of Severe COVID-19: Part Two. EMJ. [DOI: 10.33590/emj/20-00159] [Reference Citation Analysis]
175 Skulstad H, Cosyns B, Popescu BA, Galderisi M, Salvo GD, Donal E, Petersen S, Gimelli A, Haugaa KH, Muraru D, Almeida AG, Schulz-Menger J, Dweck MR, Pontone G, Sade LE, Gerber B, Maurovich-Horvat P, Bharucha T, Cameli M, Magne J, Westwood M, Maurer G, Edvardsen T. COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. Eur Heart J Cardiovasc Imaging. 2020;21:592-598. [PMID: 32242891 DOI: 10.1093/ehjci/jeaa072] [Cited by in Crossref: 130] [Cited by in F6Publishing: 111] [Article Influence: 65.0] [Reference Citation Analysis]
176 Yang H, Chi Y, Chen Z, Fan Y, Wu H, Hu X, Wu T, Xiao B, Zhang M. Differential Diagnosis and Hospital Emergency Management for Fastlane Treatment of Central Nervous System Infection Under the COVID-19 Epidemic in Changsha, China. Front Neurol 2020;11:555202. [PMID: 33192989 DOI: 10.3389/fneur.2020.555202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
177 Helms J, Combes A, Aissaoui N. Cardiac injury in COVID-19. Intensive Care Med 2021. [PMID: 34727214 DOI: 10.1007/s00134-021-06555-3] [Reference Citation Analysis]
178 Kordzadeh-Kermani E, Khalili H, Karimzadeh I. Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19). Future Microbiol 2020;15:1287-305. [PMID: 32851877 DOI: 10.2217/fmb-2020-0110] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
179 Costa IBSDS, Bittar CS, Rizk SI, Araújo Filho AE, Santos KAQ, Machado TIV, Andrade FTA, González TB, Arévalo ANG, Almeida JP, Bacal F, Oliveira GMM, Lacerda MVG, Barberato SH, Chagas ACP, Rochitte CE, Ramires JAF, Kalil Filho R, Hajjar LA. The Heart and COVID-19: What Cardiologists Need to Know. Arq Bras Cardiol 2020;114:805-16. [PMID: 32401847 DOI: 10.36660/abc.20200279] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
180 Mahmud SMH, Al-Mustanjid M, Akter F, Rahman MS, Ahmed K, Rahman MH, Chen W, Moni MA. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients. Brief Bioinform 2021:bbab115. [PMID: 33847347 DOI: 10.1093/bib/bbab115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
181 Gulati A, Pomeranz C, Qamar Z, Thomas S, Frisch D, George G, Summer R, DeSimone J, Sundaram B. A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic. Am J Med Sci 2020;360:5-34. [PMID: 32620220 DOI: 10.1016/j.amjms.2020.05.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 20.0] [Reference Citation Analysis]
182 AbdelMassih AF, Kamel A, Mishriky F, Ismail HA, El Qadi L, Malak L, El-Husseiny M, Ashraf M, Hafez N, AlShehry N, El-Husseiny N, AbdelRaouf N, Shebl N, Hafez N, Youssef N, Afdal P, Hozaien R, Menshawey R, Saeed R, Fouda R. Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19. Cardiovasc Endocrinol Metab 2020;9:110-20. [PMID: 32803145 DOI: 10.1097/XCE.0000000000000211] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
183 Palaskas NL, Koutroumpakis E, Deswal A. COVID-19 and Cardiovascular Health Among Patients with Cancer. Curr Cardiol Rep 2020;22:171. [PMID: 33040241 DOI: 10.1007/s11886-020-01421-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
184 Liang C, Zhang W, Li S, Qin G. Coronary heart disease and COVID-19: A meta-analysis. Med Clin (Barc) 2021;156:547-54. [PMID: 33632508 DOI: 10.1016/j.medcli.2020.12.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
185 Hodas R, Benedek I, Rat N, Kovacs I, Chitu M, Benedek T. Impact of COVID-19 Pandemic on STEMI Networks in Central Romania. Life (Basel) 2021;11:1004. [PMID: 34685376 DOI: 10.3390/life11101004] [Reference Citation Analysis]
186 Topol EJ. COVID-19 can affect the heart. Science 2020;370:408-9. [DOI: 10.1126/science.abe2813] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 19.0] [Reference Citation Analysis]
187 Case BC, Yerasi C, Forrestal BJ, Chezar-Azerrad C, Shea C, Rappaport H, Medranda GA, Zhang C, Satler LF, Ben-Dor I, Hashim H, Rogers T, Weintraub WS, Waksman R. The impact of COVID-19 patients with troponin elevation on renal impairment and clinical outcome. Cardiovasc Revasc Med 2021:S1553-8389(21)00248-7. [PMID: 34088598 DOI: 10.1016/j.carrev.2021.05.004] [Reference Citation Analysis]
188 Keihanian F, Bigdelu L. Cardiovascular Considerations in COVID19: A Comprehensive Review. Ther Clin Risk Manag 2020;16:1089-97. [PMID: 33204097 DOI: 10.2147/TCRM.S264377] [Reference Citation Analysis]
189 Rad HS, Röhl J, Stylianou N, Allenby MC, Bazaz SR, Warkiani ME, Guimaraes FSF, Clifton VL, Kulasinghe A. The Effects of COVID-19 on the Placenta During Pregnancy. Front Immunol 2021;12:743022. [PMID: 34603330 DOI: 10.3389/fimmu.2021.743022] [Reference Citation Analysis]
190 Philips CA, Mohan N, Ahamed R, Kumbar S, Rajesh S, George T, Mohanan M, Augustine P. One disease, many faces-typical and atypical presentations of SARS-CoV-2 infection-related COVID-19 disease. World J Clin Cases 2020; 8(18): 3956-3970 [PMID: 33024752 DOI: 10.12998/wjcc.v8.i18.3956] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
191 Khunti S, Khunti N, Seidu S, Khunti K. Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19). Diabetes Obes Metab 2020;22:1942-5. [PMID: 32319200 DOI: 10.1111/dom.14062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
192 Kong KA, Jung S, Yu M, Park J, Kang IS. Association Between Cardiovascular Risk Factors and the Severity of Coronavirus Disease 2019: Nationwide Epidemiological Study in Korea. Front Cardiovasc Med 2021;8:732518. [PMID: 34568465 DOI: 10.3389/fcvm.2021.732518] [Reference Citation Analysis]
193 Rybakova MG, Karev VE, Kuznetsova IA. [Anatomical pathology of novel coronavirus (COVID-19) infection. First impressions]. Arkh Patol 2020;82:5-15. [PMID: 33054027 DOI: 10.17116/patol2020820515] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
194 Postigo A, González-Mansilla A, Bermejo J, Elízaga J, Fernández-Avilés F, Martínez-Sellés M. Telecardiology in times of the COVID-19 pandemic. Rev Esp Cardiol (Engl Ed) 2020;73:674-5. [PMID: 32513626 DOI: 10.1016/j.rec.2020.04.018] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
195 Tersalvi G, Vicenzi M, Calabretta D, Biasco L, Pedrazzini G, Winterton D. Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms. Journal of Cardiac Failure 2020;26:470-5. [DOI: 10.1016/j.cardfail.2020.04.009] [Cited by in Crossref: 131] [Cited by in F6Publishing: 118] [Article Influence: 65.5] [Reference Citation Analysis]
196 Raman B, Bluemke DA, Lüscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J 2022:ehac031. [PMID: 35176758 DOI: 10.1093/eurheartj/ehac031] [Reference Citation Analysis]
197 Langnau C, Rohlfing AK, Gekeler S, Günter M, Pöschel S, Petersen-Uribe Á, Jaeger P, Avdiu A, Harm T, Kreisselmeier KP, Castor T, Bakchoul T, Rath D, Gawaz MP, Autenrieth SE, Mueller KAL. Platelet Activation and Plasma Levels of Furin Are Associated With Prognosis of Patients With Coronary Artery Disease and COVID-19. Arterioscler Thromb Vasc Biol 2021;41:2080-96. [PMID: 33910372 DOI: 10.1161/ATVBAHA.120.315698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Munjal M, Das S, Chatterjee N, Setra AE, Govil D. Systemic Involvement of Novel Coronavirus (COVID-19): A Review of Literature. Indian J Crit Care Med 2020;24:565-9. [PMID: 32963441 DOI: 10.5005/jp-journals-10071-23498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
199 Stawicki SP, Jeanmonod R, Miller AC, Paladino L, Gaieski DF, Yaffee AQ, De Wulf A, Grover J, Papadimos TJ, Bloem C, Galwankar SC, Chauhan V, Firstenberg MS, Di Somma S, Jeanmonod D, Garg SM, Tucci V, Anderson HL, Fatimah L, Worlton TJ, Dubhashi SP, Glaze KS, Sinha S, Opara IN, Yellapu V, Kelkar D, El-Menyar A, Krishnan V, Venkataramanaiah S, Leyfman Y, Saoud Al Thani HA, Wb Nanayakkara P, Nanda S, Cioè-Peña E, Sardesai I, Chandra S, Munasinghe A, Dutta V, Dal Ponte ST, Izurieta R, Asensio JA, Garg M. The 2019-2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper. J Glob Infect Dis 2020;12:47-93. [PMID: 32773996 DOI: 10.4103/jgid.jgid_86_20] [Cited by in Crossref: 103] [Cited by in F6Publishing: 84] [Article Influence: 51.5] [Reference Citation Analysis]
200 Oates CP, Turagam MK, Musikantow D, Chu E, Shivamurthy P, Lampert J, Kawamura I, Bokhari M, Whang W, Miller MA, Choudry S, Langan N, Sofi A, Dukkipati SR, Reddy VY, Koruth JS. Syncope and presyncope in patients with COVID-19. Pacing Clin Electrophysiol 2020;43:1139-48. [PMID: 32840325 DOI: 10.1111/pace.14047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
201 Kwenandar F, Japar KV, Damay V, Hariyanto TI, Tanaka M, Lugito NPH, Kurniawan A. Coronavirus disease 2019 and cardiovascular system: A narrative review. Int J Cardiol Heart Vasc. 2020;29:100557. [PMID: 32550259 DOI: 10.1016/j.ijcha.2020.100557] [Cited by in Crossref: 21] [Cited by in F6Publishing: 34] [Article Influence: 10.5] [Reference Citation Analysis]
202 Bende F, Tudoran C, Sporea I, Fofiu R, Bâldea V, Cotrău R, Popescu A, Sirli R, Ungureanu BS, Tudoran M. A Multidisciplinary Approach to Evaluate the Presence of Hepatic and Cardiac Abnormalities in Patients with Post-Acute COVID-19 Syndrome-A Pilot Study. J Clin Med 2021;10:2507. [PMID: 34204032 DOI: 10.3390/jcm10112507] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
203 Libenciuc C, Licu R, Hodas R, Chitu M, Benedek I. Myocardial Injury and Myocarditis in SARS-CoV-2 Patients. Journal of Interdisciplinary Medicine 2020;5:101-4. [DOI: 10.2478/jim-2020-0019] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
204 Tessitore E, Carballo D, Poncet A, Perrin N, Follonier C, Assouline B, Carballo S, Girardin F, Mach F. Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease. Open Heart 2021;8:e001526. [PMID: 33833064 DOI: 10.1136/openhrt-2020-001526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
205 Tsangaris A, Alexy T, Kalra R, Kosmopoulos M, Elliott A, Bartos JA, Yannopoulos D. Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock. Front Cardiovasc Med 2021;8:686558. [PMID: 34307500 DOI: 10.3389/fcvm.2021.686558] [Reference Citation Analysis]
206 Karetová D, Bultas J. (Coagulopathy accompanying severe forms of coronavirus infection (COVID-19) - incidence of thrombotic complications, how to prevent and treat them). Cor Vasa 2020;62:22-6. [DOI: 10.33678/cor.2020.045] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
207 Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol 2020;31:1003-8. [PMID: 32270559 DOI: 10.1111/jce.14479] [Cited by in Crossref: 238] [Cited by in F6Publishing: 213] [Article Influence: 119.0] [Reference Citation Analysis]
208 Mester A, Benedek I, Rat N, Tolescu C, Polexa SA, Benedek T. Imaging Cardiovascular Inflammation in the COVID-19 Era. Diagnostics (Basel) 2021;11:1114. [PMID: 34207266 DOI: 10.3390/diagnostics11061114] [Reference Citation Analysis]
209 Henarejos-Castillo I, Sebastian-Leon P, Devesa-Peiro A, Pellicer A, Diaz-Gimeno P. SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle. Fertil Steril 2020;114:223-32. [PMID: 32641214 DOI: 10.1016/j.fertnstert.2020.06.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
210 Mehta P, Alle S, Chaturvedi A, Swaminathan A, Saifi S, Maurya R, Chattopadhyay P, Devi P, Chauhan R, Kanakan A, Vasudevan JS, Sethuraman R, Chidambaram S, Srivastava M, Chakravarthi A, Jacob J, Namagiri M, Konala V, Jha S, Priyakumar UD, Vinod PK, Pandey R. Clinico-Genomic Analysis Reveals Mutations Associated with COVID-19 Disease Severity: Possible Modulation by RNA Structure. Pathogens 2021;10:1109. [PMID: 34578142 DOI: 10.3390/pathogens10091109] [Reference Citation Analysis]
211 Frattini S, Maccagni G, Italia L, Metra M, Danzi GB. Coronavirus disease 2019 and cardiovascular implications. J Cardiovasc Med (Hagerstown) 2020;21:725-32. [PMID: 32858623 DOI: 10.2459/JCM.0000000000001068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
212 Niazi S, Niazi F, Doroodgar F, Safi M. The Cardiac Effects of COVID-19: Review of articles. Curr Probl Cardiol 2021;:100981. [PMID: 34534589 DOI: 10.1016/j.cpcardiol.2021.100981] [Reference Citation Analysis]
213 de Farias LPG, Strabelli DG, Fonseca EKUN, Loureiro BMC, Nomura CH, Sawamura MVY. Thoracic tomographic manifestations in symptomatic respiratory patients with COVID-19. Radiol Bras 2020;53:255-61. [PMID: 32904780 DOI: 10.1590/0100-3984.2020.0030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
214 Tang L, Wang Z, Hu X, Fang Z, Zheng Z, Zeng J, Jiang L, Ouyang F, Liu C, Zeng G, Guo Y, Zhou S. Impact of the COVID-19 Pandemic on ST-Elevation Myocardial Infarction Management in Hunan Province, China: A Multi-Center Observational Study. Front Cardiovasc Med 2022;9:851214. [DOI: 10.3389/fcvm.2022.851214] [Reference Citation Analysis]
215 Yeh JJ, Lin CL, Hsu NH, Kao CH. Effects of statins and steroids on coronary artery disease and stroke in patients with interstitial lung disease and pulmonary fibrosis: A general population study. PLoS One 2021;16:e0259153. [PMID: 34705851 DOI: 10.1371/journal.pone.0259153] [Reference Citation Analysis]
216 Barman HA, Atici A, Sahin I, Dogan O, Okur O, Tugrul S, Avci I, Yildirmak MT, Gungor B, Dogan SM. Prognostic value of right ventricular strain pattern on ECG in COVID-19 patients. Am J Emerg Med 2021;49:1-5. [PMID: 34029783 DOI: 10.1016/j.ajem.2021.05.039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
217 Bisceglia I, Gabrielli D, Canale ML, Gallucci G, Parrini I, Turazza FM, Russo G, Maurea N, Quagliariello V, Lestuzzi C, Oliva S, Di Fusco SA, Lucà F, Tarantini L, Trambaiolo P, Gulizia MM, Colivicchi F. ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO). Eur Heart J Suppl 2021;23:C128-53. [PMID: 34456641 DOI: 10.1093/eurheartj/suab067] [Reference Citation Analysis]
218 Colombo CSSS, Leitão MB, Avanza Junior AC, Borges SF, Silveira ADD, Braga F, Camarozano AC, Kopiler DA, Lazzoli JK, Freitas OGA, Grossman GB, Milani M, Nunes MB, Ritt LEF, Sellera CAC, Ghorayeb N. Position Statement on Post-COVID-19 Cardiovascular Preparticipation Screening: Guidance for Returning to Physical Exercise and Sports - 2020. Arq Bras Cardiol 2021;116:1213-26. [PMID: 34133609 DOI: 10.36660/abc.20210368] [Reference Citation Analysis]
219 Pericàs JM, Hernandez-Meneses M, Sheahan TP, Quintana E, Ambrosioni J, Sandoval E, Falces C, Marcos MA, Tuset M, Vilella A, Moreno A, Miro JM; Hospital Clínic Cardiovascular Infections Study Group. COVID-19: from epidemiology to treatment. Eur Heart J 2020;41:2092-112. [PMID: 32511724 DOI: 10.1093/eurheartj/ehaa462] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 19.0] [Reference Citation Analysis]
220 van Osch D, Asselbergs FW, Teske AJ. Takotsubo cardiomyopathy in COVID-19: a case report. Haemodynamic and therapeutic considerations. Eur Heart J Case Rep 2020;4:1-6. [PMID: 33437922 DOI: 10.1093/ehjcr/ytaa271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
221 Benedek T. COVID-19 Pandemic and Cardiovascular Challenges. Journal Of Cardiovascular Emergencies 2020;6:5-6. [DOI: 10.2478/jce-2020-0003] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
222 Petrovic V, Radenkovic D, Radenkovic G, Djordjevic V, Banach M. Pathophysiology of Cardiovascular Complications in COVID-19. Front Physiol 2020;11:575600. [PMID: 33162899 DOI: 10.3389/fphys.2020.575600] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
223 Cuschieri S, Grech S. Obesity population at risk of COVID-19 complications. Glob Health Epidemiol Genom 2020;5:e6. [PMID: 33282327 DOI: 10.1017/gheg.2020.6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
224 Del Prete A, Conway F, Della Rocca DG, Biondi-zoccai G, De Felice F, Musto C, Picichè M, Martuscelli E, Natale A, Versaci F. COVID-19, Acute Myocardial Injury, and Infarction. Cardiac Electrophysiology Clinics 2021. [DOI: 10.1016/j.ccep.2021.10.004] [Reference Citation Analysis]
225 Cedrone F, Di Martino G, Di Giovanni P, Greco E, Trebbi E, Romano F, Staniscia T. Reduction in Hospital Admissions for Cardiovascular Diseases (CVDs) during the Coronavirus Disease 2019 (COVID-19) Pandemic: A Retrospective Study from a Southern Italian Region in the Year 2020. Healthcare 2022;10:871. [DOI: 10.3390/healthcare10050871] [Reference Citation Analysis]
226 Saenz LC, Miranda A, Speranza R, Texeira RA, Rojel U, Enriquez A, Figuereido M. Recommendations for the organization of electrophysiology and cardiac pacing services during the COVID-19 pandemic : Latin American Heart Rhythm Society (LAHRS) in collaboration with: Colombian College Of Electrophysiology, Argentinian Society of Cardiac Electrophysiology (SADEC), Brazilian Society Of Cardiac Arrhythmias (SOBRAC), Mexican Society Of Cardiac Electrophysiology (SOMEEC). J Interv Card Electrophysiol 2020;59:307-13. [PMID: 32350745 DOI: 10.1007/s10840-020-00747-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
227 Weizman O, Mika D, Cellier J, Geneste L, Trimaille A, Pommier T, Panagides V, Marsou W, Deney A, Attou S, Delmotte T, Ribeyrolles S, Chemaly P, Karsenty C, Giordano G, Gautier A, Chaumont C, Guilleminot P, Sagnard A, Pastier J, Duceau B, Sutter W, Fauvel C, Pezel T, Bonnet G, Cohen A, Waldmann V; Critical COVID-19 France Investigators. Characteristics and impact of cardiovascular comorbidities on coronavirus disease 2019 in women: A multicentre cohort study. Arch Cardiovasc Dis 2021;114:394-406. [PMID: 34154954 DOI: 10.1016/j.acvd.2021.04.002] [Reference Citation Analysis]
228 Vukomanovic V, Krasic S, Minic P, Petrovic G, Nesic D, Paripovic A, Vasiljevic M, Gobeljic B. Kawasaki-like disease and acute myocarditis in the SARS-CoV-2 pandemic - reports of three adolescents. Bosn J Basic Med Sci 2021;21:252. [PMID: 33119481 DOI: 10.17305/bjbms.2020.5037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
229 Bursi F, Santangelo G, Sansalone D, Valli F, Vella AM, Toriello F, Barbieri A, Carugo S. Prognostic utility of quantitative offline 2D-echocardiography in hospitalized patients with COVID-19 disease. Echocardiography 2020;37:2029-39. [PMID: 32964483 DOI: 10.1111/echo.14869] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
230 Jamwal S, Gautam A, Elsworth J, Kumar M, Chawla R, Kumar P. An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic. Life Sci 2020;257:118105. [PMID: 32687917 DOI: 10.1016/j.lfs.2020.118105] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
231 Viswanathan V, Puvvula A, Jamthikar AD, Saba L, Johri AM, Kotsis V, Khanna NN, Dhanjil SK, Majhail M, Misra DP, Agarwal V, Kitas GD, Sharma AM, Kolluri R, Naidu S, Suri JS. Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review. World J Diabetes 2021; 12(3): 215-237 [PMID: 33758644 DOI: 10.4239/wjd.v12.i3.215] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
232 Liu Z, Li J, Li M, Chen S, Gao R, Zeng G, Chen D, Wang S, Li Q, Hu D, Zeng W, Guo L, Wu X. Elevated α-hydroxybutyrate dehydrogenase as an independent prognostic factor for mortality in hospitalized patients with COVID-19. ESC Heart Fail 2021;8:644-51. [PMID: 33336560 DOI: 10.1002/ehf2.13151] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
233 Çelik Z, Güzel NA, Kafa N, Köktürk N. Respiratory muscle strength in volleyball players suffered from COVID-19. Ir J Med Sci 2021. [PMID: 34748144 DOI: 10.1007/s11845-021-02849-z] [Reference Citation Analysis]
234 Amir M, Yoseph H, Farisi ATA, Phie JKP, Adam ATS. Symptomatic Bradycardia in Covid-19 Hospitalized Patients: A Case Series. Int J Infect Dis 2021;111:1-4. [PMID: 34333120 DOI: 10.1016/j.ijid.2021.07.068] [Reference Citation Analysis]
235 Liu X, Lou L, Zhou L. Molecular Mechanisms of Cardiac Injury Associated With Myocardial SARS-CoV-2 Infection. Front Cardiovasc Med 2022;8:643958. [DOI: 10.3389/fcvm.2021.643958] [Reference Citation Analysis]
236 Augoustides JGT. The Renin-Angiotensin-Aldosterone System in Coronavirus Infection-Current Considerations During the Pandemic. J Cardiothorac Vasc Anesth. 2020;34:1717-1719. [PMID: 32360010 DOI: 10.1053/j.jvca.2020.04.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
237 Wang Y, Wang Z, Tse G, Zhang L, Wan EY, Guo Y, Lip GYH, Li G, Lu Z, Liu T. Cardiac arrhythmias in patients with COVID-19. J Arrhythm 2020;36:827-36. [PMID: 33024460 DOI: 10.1002/joa3.12405] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 12.5] [Reference Citation Analysis]
238 Shanmugam C, Mohammed AR, Ravuri S, Luthra V, Rajagopal N, Karre S. COVID-2019 - A comprehensive pathology insight. Pathol Res Pract. 2020;216:153222. [PMID: 32979742 DOI: 10.1016/j.prp.2020.153222] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
239 Maloberti A, Ughi N, Bernasconi DP, Rebora P, Cartella I, Grasso E, Lenoci D, Del Gaudio F, Algeri M, Scarpellini S, Perna E, Verde A, Santolamazza C, Vicari F, Frigerio M, Alberti A, Valsecchi MG, Rossetti C, Epis OM, Giannattasio C, On The Behalf Of The Niguarda Covid-Working Group. Heart Rate in Patients with SARS-CoV-2 Infection: Prevalence of High Values at Discharge and Relationship with Disease Severity. J Clin Med 2021;10:5590. [PMID: 34884293 DOI: 10.3390/jcm10235590] [Reference Citation Analysis]
240 Sliwa K, Singh K, Raspail L, Ojji D, Lam CSP, Thienemann F, Ge J, Banerjee A, Newby LK, Ribeiro ALP, Gidding S, Pinto F, Perel P, Prabhakaran D. The World Heart Federation Global Study on COVID-19 and Cardiovascular Disease. Glob Heart 2021;16:22. [PMID: 34040935 DOI: 10.5334/gh.950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
241 Baral R, Tsampasian V, Debski M, Moran B, Garg P, Clark A, Vassiliou VS. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis. JAMA Netw Open 2021;4:e213594. [PMID: 33787911 DOI: 10.1001/jamanetworkopen.2021.3594] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
242 Lavie G, Battat E, Saliba W, Flugelman MY. Change in hospitalizations and 30-day mortality of patients with acute myocardial infarction during the first COVID-19 lockdown - A pure social isolation effect? Cardiovasc Revasc Med 2021:S1553-8389(21)00631-X. [PMID: 34483076 DOI: 10.1016/j.carrev.2021.08.025] [Reference Citation Analysis]
243 Goha A, Mezue K, Edwards P, Nunura F, Baugh D, Madu E. COVID-19 and the heart: An update for clinicians. Clin Cardiol 2020;43:1216-22. [PMID: 32533585 DOI: 10.1002/clc.23406] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
244 Shiravi AA, Saadatkish M, Abdollahi Z, Miar P, Khanahmad H, Zeinalian M. Vitamin D can be effective on the prevention of COVID-19 complications: A narrative review on molecular aspects. Int J Vitam Nutr Res 2020;:1-13. [PMID: 32811354 DOI: 10.1024/0300-9831/a000676] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
245 Sherif EM, Elhenawy YI, Matter RM, Aly HH, Thabet RA, Fereig YA. Clinical characteristics and outcome of hospitalized children and adolescent patients with type 1 diabetes during the COVID-19 pandemic: data from a single center surveillance study in Egypt. J Pediatr Endocrinol Metab 2021;34:925-36. [PMID: 33882200 DOI: 10.1515/jpem-2021-0099] [Reference Citation Analysis]
246 Sheikh AB, Shekhar R, Javed N, Upadhyay S. Inferior Wall Myocardial Infarction in Severe COVID-19 Infection: A Case Report. Am J Case Rep 2020;21:e926101. [PMID: 32981926 DOI: 10.12659/AJCR.926101] [Reference Citation Analysis]
247 Hache G, Rolain JM, Gautret P, Deharo JC, Brouqui P, Raoult D, Honoré S. Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity. Microb Drug Resist 2021;27:281-90. [PMID: 33729874 DOI: 10.1089/mdr.2020.0232] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
248 Song Y, Gao P, Ran T, Qian H, Guo F, Chang L, Wu W, Zhang S. High Inflammatory Burden: A Potential Cause of Myocardial Injury in Critically Ill Patients With COVID-19. Front Cardiovasc Med 2020;7:128. [PMID: 32733921 DOI: 10.3389/fcvm.2020.00128] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
249 Crea F. Prevention of cardiovascular diseases and dementia: the emerging role of air pollution, socioeconomic factors, e-cigarettes, new biomarkers, proteomics, and genetics. Eur Heart J 2020;41:3969-72. [PMID: 33205819 DOI: 10.1093/eurheartj/ehaa896] [Reference Citation Analysis]
250 Arumugam VA, Thangavelu S, Fathah Z, Ravindran P, Sanjeev AMA, Babu S, Meyyazhagan A, Yatoo MI, Sharun K, Tiwari R, Pandey MK, Sah R, Chandra R, Dhama K. COVID-19 and the World with Co-Morbidities of Heart Disease, Hypertension and Diabetes. J Pure Appl Microbiol 2020;14:1623-38. [DOI: 10.22207/jpam.14.3.01] [Cited by in Crossref: 13] [Article Influence: 6.5] [Reference Citation Analysis]
251 Beşler MS, Arslan H. Acute myocarditis associated with COVID-19 infection. Am J Emerg Med 2020;38:2489.e1-2. [PMID: 32507570 DOI: 10.1016/j.ajem.2020.05.100] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
252 Kapoor MC. Respiratory and cardiovascular effects of COVID-19 infection and their management. J Anaesthesiol Clin Pharmacol 2020;36:S21-8. [PMID: 33100642 DOI: 10.4103/joacp.JOACP_242_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
253 Laza R, Lazureanu VE, Musta VF, Nicolescu ND, Vernic C, Tudor A, Critu R, Vilceanu L, Paczeyka R, Bica Profir V, Marinescu AR, Mocanu A, Cut TG, Lighezan DF, Baditoiu LM. COVID-19 Independent Risk Factors for Unfavorable Disease Progression: A Cross-Sectional Study from Romania. IJGM 2022;Volume 15:2025-36. [DOI: 10.2147/ijgm.s350920] [Reference Citation Analysis]
254 Natarelli L, Virgili F, Weber C. SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad. Int J Mol Sci 2021;22:12243. [PMID: 34830125 DOI: 10.3390/ijms222212243] [Reference Citation Analysis]
255 Kogan EA, Berezovsky YS, Kukleva AD, Kurilina EV, Semenova LA, Blagova OV, Zharkov NV. [Lymphocytic myocarditis in patients with COVID-19 (4 autopsy cases)]. Arkh Patol 2020;82:57-62. [PMID: 33054033 DOI: 10.17116/patol20208205157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
256 Li X, Guan B, Su T, Liu W, Chen M, Bin Waleed K, Guan X, Gary T, Zhu Z. Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis. Heart 2020;106:1142-7. [PMID: 32461330 DOI: 10.1136/heartjnl-2020-317062] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 29.0] [Reference Citation Analysis]
257 Awad WI, Bashir M. Mechanical circulatory support-Challenges, strategies, and preparations. J Card Surg 2021;36:1723-8. [PMID: 33442894 DOI: 10.1111/jocs.15301] [Reference Citation Analysis]
258 Matsushita K, Marchandot B, Jesel L, Ohlmann P, Morel O. Impact of COVID-19 on the Cardiovascular System: A Review. J Clin Med 2020;9:E1407. [PMID: 32397558 DOI: 10.3390/jcm9051407] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
259 Eren MT, Özveri H, Kurtoğlu H. Penile Mondor's in a Covid-19 patient on prophylactic anti-thrombosis with rivaroxaban: a case report. Afr J Urol 2021;27:97. [PMID: 34248351 DOI: 10.1186/s12301-021-00200-7] [Reference Citation Analysis]
260 Afriyie F, Fohle E, Dekowski SS, Kumar S. A Case of Isolated SARS-CoV-2 Fulminant Myopericarditis Without Respiratory Failure. Cureus 2021;13:e14003. [PMID: 33884244 DOI: 10.7759/cureus.14003] [Reference Citation Analysis]
261 Italia L, Tomasoni D, Bisegna S, Pancaldi E, Stretti L, Adamo M, Metra M. COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae. Front Cardiovasc Med 2021;8:713560. [PMID: 34447795 DOI: 10.3389/fcvm.2021.713560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
262 Raza HA, Tariq J, Agarwal V, Gupta L. COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases. Rheumatol Int 2021;41:257-73. [PMID: 33386447 DOI: 10.1007/s00296-020-04759-2] [Reference Citation Analysis]
263 Kamyshnyi A, Krynytska I, Matskevych V, Marushchak M, Lushchak O. Arterial Hypertension as a Risk Comorbidity Associated with COVID-19 Pathology. Int J Hypertens 2020;2020:8019360. [PMID: 33489355 DOI: 10.1155/2020/8019360] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
264 El Rhalete A, Rhazi I, Bensaid A, Zaid I, Bkiyer H, Ismaili N, Elouafi N, Housni B. Cardiovascular injuries during COVID-19 infection: A PROCESS-compliant case series from the Eastern Morocco. Ann Med Surg (Lond) 2021;65:102309. [PMID: 33898022 DOI: 10.1016/j.amsu.2021.102309] [Reference Citation Analysis]
265 Lee CCE, Ali K, Connell D, Mordi IR, George J, Lang EM, Lang CC. COVID-19-Associated Cardiovascular Complications. Diseases 2021;9:47. [PMID: 34209705 DOI: 10.3390/diseases9030047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
266 Marchandot B, Sattler L, Jesel L, Matsushita K, Schini-Kerth V, Grunebaum L, Morel O. COVID-19 Related Coagulopathy: A Distinct Entity? J Clin Med 2020;9:E1651. [PMID: 32486469 DOI: 10.3390/jcm9061651] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 25.5] [Reference Citation Analysis]
267 Khera A, Baum SJ, Gluckman TJ, Gulati M, Martin SS, Michos ED, Navar AM, Taub PR, Toth PP, Virani SS, Wong ND, Shapiro MD. Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology. Am J Prev Cardiol 2020;1:100009. [PMID: 32835347 DOI: 10.1016/j.ajpc.2020.100009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
268 Kim IC, Kim HA, Park JS, Nam CW. Updates of Cardiovascular Manifestations in COVID-19: Korean Experience to Broaden Worldwide Perspectives. Korean Circ J 2020;50:543-54. [PMID: 32588565 DOI: 10.4070/kcj.2020.0205] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
269 Canal B, McClure AW, Curran JF, Wu M, Ulferts R, Weissmann F, Zeng J, Bertolin AP, Milligan JC, Basu S, Drury LS, Deegan TD, Fujisawa R, Roberts EL, Basier C, Labib K, Beale R, Howell M, Diffley JFX. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease. Biochem J 2021;478:2445-64. [PMID: 34198326 DOI: 10.1042/BCJ20210198] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
270 Cizgici AY, Zencirkiran Agus H, Yildiz M. COVID-19 myopericarditis: It should be kept in mind in today's conditions. Am J Emerg Med 2020;38:1547.e5-6. [PMID: 32360119 DOI: 10.1016/j.ajem.2020.04.080] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
271 Ceccarini G, Gilio D, Magno S, Pelosini C, Leverone M, Miceli C, Barison A, Fabiani I, Emdin M, Santini F. Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation. J Endocrinol Invest 2022. [PMID: 35384599 DOI: 10.1007/s40618-022-01795-6] [Reference Citation Analysis]
272 Pavlović S. Cardiovascular diseases and complication in COVID-19. Medicinski podmladak 2021;72:65-9. [DOI: 10.5937/mp72-33011] [Reference Citation Analysis]
273 Gopal K, Krishna N, Jose R, Biju SSC, Pichandi JS, Varma PK. Effects of the COVID-19 Pandemic on Cardiac Surgery Practice and Outcomes. J Chest Surg 2022;55:61-8. [PMID: 35115424 DOI: 10.5090/jcs.21.125] [Reference Citation Analysis]
274 Singh B, Mal G, Verma V, Tiwari R, Khan MI, Mohapatra RK, Mitra S, Alyami SA, Emran TB, Dhama K, Moni MA. Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era. Stem Cell Res Ther 2021;12:283. [PMID: 33980321 DOI: 10.1186/s13287-021-02334-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
275 Settelmeier S, Rassaf T, Giannitsis E, Münzel T, Breuckmann F. Capacity changes in German certified chest pain units during COVID-19 outbreak response. Clin Res Cardiol 2020;109:1469-75. [PMID: 32476041 DOI: 10.1007/s00392-020-01676-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
276 Greco S, Madè A, Gaetano C, Devaux Y, Emanueli C, Martelli F. Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era. J Transl Med 2020;18:408. [PMID: 33129318 DOI: 10.1186/s12967-020-02582-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
277 Çiftel M, Ateş N, Yılmaz O. Investigation of endothelial dysfunction and arterial stiffness in multisystem inflammatory syndrome in children. Eur J Pediatr 2021. [PMID: 34212240 DOI: 10.1007/s00431-021-04136-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Onnis C, Muscogiuri G, Paolo Bassareo P, Cau R, Mannelli L, Cadeddu C, Suri JS, Cerrone G, Gerosa C, Sironi S, Faa G, Carriero A, Pontone G, Saba L. Non-invasive coronary imaging in patients with COVID-19: a narrative review. European Journal of Radiology 2022. [DOI: 10.1016/j.ejrad.2022.110188] [Reference Citation Analysis]
279 Seoudy H, Frey N. [COVID-19 and the impact of cardiovascular comorbidities]. Dtsch Med Wochenschr 2020;145:1157-60. [PMID: 32791552 DOI: 10.1055/a-1158-5996] [Reference Citation Analysis]
280 Aung AH, Lye DC, Cui L, Ooi CK, Chow ALP. The "timeless" use of influenza-like illness criteria for influenza detection in the tropics. Int J Infect Dis 2021;106:160-8. [PMID: 33741485 DOI: 10.1016/j.ijid.2021.03.045] [Reference Citation Analysis]
281 Bhasin V, Carrillo M, Ghosh B, Moin D, Maglione TJ, Kassotis J. Reversible complete heart block in a patient with coronavirus disease 2019. Pacing Clin Electrophysiol 2021;44:1939-43. [PMID: 34289133 DOI: 10.1111/pace.14321] [Reference Citation Analysis]
282 Müller-Wieland D, Marx N, Dreher M, Fritzen K, Schnell O. COVID-19 and Cardiovascular Comorbidities. Exp Clin Endocrinol Diabetes 2020. [PMID: 33157558 DOI: 10.1055/a-1269-1405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
283 Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;75:2950-73. [PMID: 32311448 DOI: 10.1016/j.jacc.2020.04.031] [Cited by in Crossref: 1202] [Cited by in F6Publishing: 1150] [Article Influence: 601.0] [Reference Citation Analysis]
284 Zaky S, Alboraie M, El Badry M, Metwally MA, Abdelaziz A, Fouad Y, Abd-Elsalam S, Mahmoud A, Shiha G, Baki AA, El Kassas M, Esmat G. Management of liver disease patients in different clinical situations during COVID-19 pandemic. Egypt Liver J 2021;11:21. [PMID: 34777868 DOI: 10.1186/s43066-021-00091-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
285 Farmani AR, Mahdavinezhad F, Moslemi R, Mehrabi Z, Noori A, Kouhestani M, Noroozi Z, Ai J, Rezaei N. Anti-IgE monoclonal antibodies as potential treatment in COVID-19. Immunopharmacol Immunotoxicol 2021;43:259-64. [PMID: 34018464 DOI: 10.1080/08923973.2021.1925906] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
286 Agdamag ACC, Edmiston JB, Charpentier V, Chowdhury M, Fraser M, Maharaj VR, Francis GS, Alexy T. Update on COVID-19 Myocarditis. Medicina (Kaunas) 2020;56:E678. [PMID: 33317101 DOI: 10.3390/medicina56120678] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
287 Talasaz AH, Kakavand H, Van Tassell B, Aghakouchakzadeh M, Sadeghipour P, Dunn S, Geraiely B. Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective. Cardiovasc Drugs Ther 2021;35:249-59. [PMID: 32671601 DOI: 10.1007/s10557-020-07037-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
288 Kowalik MM, Trzonkowski P, Łasińska-Kowara M, Mital A, Smiatacz T, Jaguszewski M. COVID-19 - Toward a comprehensive understanding of the disease. Cardiol J 2020;27:99-114. [PMID: 32378729 DOI: 10.5603/CJ.a2020.0065] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
289 Prabhakaran D, Perel P, Roy A, Singh K, Raspail L, Faria-Neto JR, Gidding SS, Ojji D, Hakim F, Newby LK, Stępińska J, Lam CSP, Jobe M, Kraus S, Chuquiure-Valenzuela E, Piñeiro D, Khaw KT, Bahiru E, Banerjee A, Narula J, Pinto FJ, Wood DA, Sliwa K. Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings. Glob Heart 2020;15:44. [PMID: 32923338 DOI: 10.5334/gh.823] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
290 Nader J, Anselmi A, Tomasi J, Martin A, Aymami M, Rouze S, Corbineau H, Langanay T, Flecher E, Nesseler N, Verhoye JP. Adult cardiac surgery during COVID-19 lockdown: Impact on activity and outcomes in a high-volume centre. Arch Cardiovasc Dis 2021;114:364-70. [PMID: 33541832 DOI: 10.1016/j.acvd.2020.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
291 Padilla S, Telenti G, Guillén L, García JA, García-Abellán J, Ding C, Mora A, García-Pachón E, Gutiérrez F, Masiá M; COVID19-Elx Group. Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19. Int J Antimicrob Agents 2020;56:106142. [PMID: 32853675 DOI: 10.1016/j.ijantimicag.2020.106142] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
292 Gupta R, Das MK, Mohanan PP, Deb PK, Parashar SK, Chopra HK, Shrivastava S, Guha S, Goswami KC, Yadav R, Alagesan R, Amuthan V, Bansal M, Chakraborty RN, Chakraborti N, Chandra S, Chatterjee A, Chatterjee D, Chatterjee SS, Dutta AL, De A, Garg A, Garg VK, Goyal A, Goyal NK, Govind SC, Gupta VK, Hasija PK, Jabir A, Jain P, Jain V, Jayagopal PB, Kasliwal RR, Katyal VK, Kerkar PG, Khan AK, Khanna NN, Mandal M, Majumder B, Mishra SS, Meena CB, Naik N, Narain VS, Pancholia AK, Pathak LA, Ponde CK, Raghu K, Ray S, Roy D, Sarma D, Shanmugasundarum S, Singh BP, Tyagi S, Vijayaraghavan G, Wander GS, Wardhan H, Nanda NC. Cardiological society of India document on safety measure during echo evaluation of cardiovascular disease in the time of COVID-19. Indian Heart J 2020;72:145-50. [PMID: 32768012 DOI: 10.1016/j.ihj.2020.05.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
293 Al-Wahaibi K, Al-Wahshi Y, Mohamed Elfadil O. Myocardial Injury Is Associated with Higher Morbidity and Mortality in Patients with 2019 Novel Coronavirus Disease (COVID-19). SN Compr Clin Med 2020;:1-7. [PMID: 33052322 DOI: 10.1007/s42399-020-00569-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
294 Liu H, Gai S, Wang X, Zeng J, Sun C, Zhao Y, Zheng Z. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart. Cardiovasc Res 2020;116:1733-41. [PMID: 32638018 DOI: 10.1093/cvr/cvaa191] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
295 Monroe I, Dale M, Schwabe M, Schenkel R, Schenarts PJ. The COVID-19 Patient in the Surgical Intensive Care Unit. Surg Clin North Am 2022;102:1-21. [PMID: 34800379 DOI: 10.1016/j.suc.2021.09.015] [Reference Citation Analysis]
296 Raffaello WM, Huang I, Budi Siswanto B, Pranata R. In-depth review of cardiopulmonary support in COVID-19 patients with heart failure. World J Cardiol 2021; 13(8): 298-308 [PMID: 34589166 DOI: 10.4330/wjc.v13.i8.298] [Reference Citation Analysis]
297 Dumantepe M, Aydin S, Yildiz E, Okur HK, Kocagoz AS, Gundogdu Y, Okten M, Isbir S, Karabulut H. WITHDRAWN: Subsegmental Thrombus in COVID-19 Pneumonia: Immuno-Thrombosis or Pulmonary Embolism? Data Analysis of Hospitalized Patients with Coronavirus Disease. Heart Lung Circ 2020:S1443-9506(20)30435-2. [PMID: 32917551 DOI: 10.1016/j.hlc.2020.08.003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
298 Xiong TY, Huang FY, Liu Q, Peng Y, Xu YN, Wei JF, Li N, Bai B, Li JH, Prendergast B, Li WM, Chen M. Hypertension is a risk factor for adverse outcomes in patients with coronavirus disease 2019: a cohort study. Ann Med 2020;52:361-6. [PMID: 32716217 DOI: 10.1080/07853890.2020.1802059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
299 Mercurio AM, Gianakos AL, Mulcahey MK, Sutton KM. Five Myths of COVID-19 for the Team Physician. HSS J 2020;:1-6. [PMID: 32929321 DOI: 10.1007/s11420-020-09793-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
300 Bhatia M, Kumar PA. Pro: Venoarterial ECMO Should Be Considered in Patients With COVID-19. J Cardiothorac Vasc Anesth 2021;35:703-6. [PMID: 33288430 DOI: 10.1053/j.jvca.2020.11.027] [Reference Citation Analysis]
301 Rowland B, Kunadian V. Challenges in the management of older patients with acute coronary syndromes in the COVID-19 pandemic. Heart 2020;106:1296-301. [PMID: 32444504 DOI: 10.1136/heartjnl-2020-317011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
302 Nappi F, Giacinto O, Ellouze O, Nenna A, Avtaar Singh SS, Chello M, Bouzguenda A, Copie X. Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review. Biomedicines 2022;10:702. [DOI: 10.3390/biomedicines10030702] [Reference Citation Analysis]
303 Heberto AB, Carlos PCJ, Antonio CRJ, Patricia PP, Enrique TR, Danira MPJ, Benito GÁE, Alfredo MRJ. Implications of myocardial injury in Mexican hospitalized patients with coronavirus disease 2019 (COVID-19). Int J Cardiol Heart Vasc 2020;30:100638. [PMID: 32953968 DOI: 10.1016/j.ijcha.2020.100638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
304 Hanson PJ, Liu-Fei F, Minato TA, Hossain AR, Rai H, Chen VA, Ng C, Ask K, Hirota JA, McManus BM. Advanced detection strategies for cardiotropic virus infection in a cohort study of heart failure patients. Lab Invest 2021. [PMID: 34608239 DOI: 10.1038/s41374-021-00669-4] [Reference Citation Analysis]
305 Alonso-Fernández A, Toledo-Pons N, Cosío BG, Millán A, Calvo N, Ramón L, de Mendoza SH, Morell-García D, Bauça-Rossello JM, Núñez B, Pons J, Palmer JA, Martín L, Peñaranda M, Pou JA, Sauleda J, Sala-Llinas E. Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: A prospective study. PLoS One 2020;15:e0238216. [PMID: 32841275 DOI: 10.1371/journal.pone.0238216] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
306 Keri VC, Hooda A, Kodan P, R L B, Jorwal P, Wig N. Intricate interplay between Covid-19 and cardiovascular diseases. Rev Med Virol 2021;31:e2188. [PMID: 33128859 DOI: 10.1002/rmv.2188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
307 You H, Zhao Q, Dong M. The Key Genes Underlying Pathophysiology Correlation Between the Acute Myocardial Infarction and COVID-19. IJGM 2022;Volume 15:2479-90. [DOI: 10.2147/ijgm.s354885] [Reference Citation Analysis]
308 Ogah OS, Umuerri EM, Adebiyi A, Orimolade OA, Sani MU, Ojji DB, Mbakwem AC, Stewart S, Sliwa K. SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications. Glob Heart 2021;16:18. [PMID: 33833942 DOI: 10.5334/gh.829] [Reference Citation Analysis]
309 Kheir M, Saleem F, Wang C, Mann A, Chua J. Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19. PLoS One 2021;16:e0248358. [PMID: 33725003 DOI: 10.1371/journal.pone.0248358] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
310 Gardin C, Ferroni L, Chachques JC, Zavan B. Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients? J Clin Med 2020;9:E2762. [PMID: 32858940 DOI: 10.3390/jcm9092762] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
311 Akkawi AR, Ghazal M. COVID-19 and Cardiac Arrhythmias: A Review of the Literature. Cureus 2021;13:e17797. [PMID: 34660007 DOI: 10.7759/cureus.17797] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
312 Kelle S, Bucciarelli-Ducci C, Judd RM, Kwong RY, Simonetti O, Plein S, Raimondi F, Weinsaft JW, Wong TC, Carr J. Society for Cardiovascular Magnetic Resonance (SCMR) recommended CMR protocols for scanning patients with active or convalescent phase COVID-19 infection.J Cardiovasc Magn Reson. 2020;22:61. [PMID: 32878639 DOI: 10.1186/s12968-020-00656-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
313 Ayan A, Kıraç FS. Guide for Nuclear Medicine Applications During the COVID-19 Outbreak. Mol Imaging Radionucl Ther 2020;29:49-58. [PMID: 32368875 DOI: 10.4274/mirt.galenos.2020.33600] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
314 Postigo A, González-Mansilla A, Bermejo J, Elízaga J, Fernández-Avilés F, Martínez-Sellés M. [Telecardiology in times of the COVID-19 pandemic]. Rev Esp Cardiol 2020;73:674-6. [PMID: 32372843 DOI: 10.1016/j.recesp.2020.04.026] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
315 Abdelzaher H, Saleh BM, Ismail HA, Hafiz M, Gabal MA, Mahmoud M, Hashish S, Gawad RMA, Gharieb RY, Abdelnaser A. COVID-19 Genetic and Environmental Risk Factors: A Look at the Evidence. Front Pharmacol 2020;11:579415. [PMID: 33117174 DOI: 10.3389/fphar.2020.579415] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
316 Case BC, Abramowitz J, Shea C, Rappaport H, Medranda GA, Yerasi C, Forrestal BJ, Chezar-Azerrad C, Zhang C, Satler LF, Ben-Dor I, Hashim H, Rogers T, Weintraub WS, Waksman R. Comparison of Outcomes in Patients With COVID-19 and Thrombosis Versus Those Without Thrombosis. Am J Cardiol 2021;160:106-11. [PMID: 34607645 DOI: 10.1016/j.amjcard.2021.08.038] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
317 Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: Possible mechanisms. Life Sci 2020;253:117723. [PMID: 32360126 DOI: 10.1016/j.lfs.2020.117723] [Cited by in Crossref: 127] [Cited by in F6Publishing: 115] [Article Influence: 63.5] [Reference Citation Analysis]
318 Brown SA, Zaharova S, Mason P, Thompson J, Thapa B, Ishizawar D, Wilkes E, Ahmed G, Rubenstein J, Sanchez J, Joyce D, Kalyanaraman B, Widlansky M. Pandemic Perspective: Commonalities Between COVID-19 and Cardio-Oncology. Front Cardiovasc Med 2020;7:568720. [PMID: 33344513 DOI: 10.3389/fcvm.2020.568720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
319 Mengal N, Saghir T, Hassan Rizvi SN, Khan N, Qamar N, Masood S, Badini A. Acute ST-Elevation Myocardial Infarction Before and During the COVID-19 Pandemic: What is the Clinically Significant Difference? Cureus 2020;12:e10523. [PMID: 33094064 DOI: 10.7759/cureus.10523] [Reference Citation Analysis]
320 Katz JN, Sinha SS, Alviar CL, Dudzinski DM, Gage A, Brusca SB, Flanagan MC, Welch T, Geller BJ, Miller PE, Leonardi S, Bohula EA, Price S, Chaudhry SP, Metkus TS, O'Brien CG, Sionis A, Barnett CF, Jentzer JC, Solomon MA, Morrow DA, van Diepen S. COVID-19 and Disruptive Modifications to Cardiac Critical Care Delivery: JACC Review Topic of the Week. J Am Coll Cardiol 2020;76:72-84. [PMID: 32305402 DOI: 10.1016/j.jacc.2020.04.029] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
321 Kelesoglu S, Yilmaz Y, Ozkan E, Calapkorur B, Gok M, Dursun ZB, Kilic AU, Demirelli S, Simsek Z, Elcık D. New onset atrial fibrilation and risk faktors in COVID-19. J Electrocardiol 2021;65:76-81. [PMID: 33556739 DOI: 10.1016/j.jelectrocard.2020.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
322 Qian H, Gao P, Tian R, Yang X, Guo F, Li T, Liu Z, Wang J, Zhou X, Qin Y, Chang L, Song Y, Yan X, Wu W, Zhang S. Myocardial Injury on Admission as a Risk in Critically Ill COVID-19 Patients: A Retrospective in-ICU Study. J Cardiothorac Vasc Anesth 2021;35:846-53. [PMID: 33162306 DOI: 10.1053/j.jvca.2020.10.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
323 Altamimi H, Abid AR, Othman F, Patel A. Cardiovascular Manifestations of COVID-19. Heart Views 2020;21:171-86. [PMID: 33688409 DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_150_20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
324 Holy EW, Jakob P, Manka R, Stähli BE, Siegrist PT, Ruschitzka F, Templin C. Impact of a nationwide COVID-19 lockdown on acute coronary syndrome referrals. Cardiol J 2020;27:633-5. [PMID: 32643140 DOI: 10.5603/CJ.a2020.0091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
325 Çevik BŞ, Arıcı Ş, Ergenç Z, Kepenekli E, Günal Ö, Yakut N. How safe are children with COVID-19 from cardiac risks? Pediatric risk assesment; insights from echocardiography and electrocardiography. Turk J Med Sci 2021;51:981-90. [PMID: 33517608 DOI: 10.3906/sag-2010-240] [Reference Citation Analysis]
326 Mueller KAL, Langnau C, Günter M, Pöschel S, Gekeler S, Petersen-Uribe Á, Kreisselmeier KP, Klingel K, Bösmüller H, Li B, Jaeger P, Castor T, Rath D, Gawaz MP, Autenrieth SE. Numbers and phenotype of non-classical CD14dimCD16+ monocytes are predictors of adverse clinical outcome in patients with coronary artery disease and severe SARS-CoV-2 infection. Cardiovasc Res 2021;117:224-39. [PMID: 33188677 DOI: 10.1093/cvr/cvaa328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
327 Chakraborty R, Parvez S. COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials. Biochem Pharmacol 2020;180:114184. [PMID: 32739342 DOI: 10.1016/j.bcp.2020.114184] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
328 Kurdi H, Obaid DR, UlHaq Z, Ionescu A, Sekar B. Multiple spontaneous coronary thrombosis causing ST-elevation myocardial infarction in a patient with COVID-19. Br J Hosp Med (Lond) 2020;81:1-6. [PMID: 32730159 DOI: 10.12968/hmed.2020.0337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
329 Laino ME, Ammirabile A, Motta F, De Santis M, Savevski V, Francone M, Chiti A, Mannelli L, Selmi C, Monti L. Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement. Clin Rev Allergy Immunol 2022. [PMID: 35089505 DOI: 10.1007/s12016-022-08925-1] [Reference Citation Analysis]
330 Cappannoli L, Scacciavillani R, Iannaccone G, Anastasia G, Di Giusto F, Loria V, Aspromonte N. 2019 novel-coronavirus: Cardiovascular insights about risk factors, myocardial injury, therapy and clinical implications. Chronic Dis Transl Med 2020;6:246-50. [PMID: 32837764 DOI: 10.1016/j.cdtm.2020.06.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
331 Shaw PD, Rao AP, Malik P. Cardiac complications of COVID-19: the concealed realities. Infect Dis (Lond) 2021;53:137-8. [PMID: 33164604 DOI: 10.1080/23744235.2020.1841908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]